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Abstract 
Pain is considered to have an effect on muscle activity and movement and although 
there has been much research as to these effects, controversy still exists as to the 
nature of the association. About 10% of Temporomandibular Disorders (TMD) 
patients progress to chronic pain and disability and it is unclear why some patients 
progress to chronic TMD while others do not. Genetic factors and deficiencies in 
central pain modulatory systems have been implicated as possible reasons. Another 
factor that might contribute to the transition from acute to chronic TMD pain is that 
the jaw motor system may develop a new pattern of jaw movement and muscle 
activity in some individuals who experience an acute episode of jaw muscle pain and 
this new pattern may actually generate more pain. The general hypothesis of this 
thesis therefore is that following a resolution of a brief episode of orofacial pain, there 
are significant changes in jaw motor activity that persist beyond the period of pain. 
Aims: The first aim was to determine whether a continuous infusion of hypertonic 
saline results in significant changes in jaw movement velocity and amplitude during 
chewing in comparison with control. The second aim was to investigate whether a 
continuous infusion of hypertonic saline results in significant changes in jaw 
movement velocity and amplitude during chewing in comparison with control and 
which are apparent after the resolution of the pain following cessation of the infusion 
of hypertonic saline. 
Methods: Chewing jaw movements were recorded during free chewing and chewing 
standardized for rate, in 10 asymptomatic participants (experimental pain group) in 4 
blocks: baseline block, block 1 (during continuous infusion of 5% hypertonic saline into 
the right masseter muscle), block 2 (10 minutes after end of block 1), block 3 (5 
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minutes after end of block 2). The same procedure without injection was carried out in 
an additional 10 participants (control group). The age range of the participants was 20 
to 39 (mean age: 29.5) for the control group, and 24 to 38 age range (mean age: 28.0) 
for the pain group. There were 5 males and 5 females in the control group, and 3 
males and 7 females in the pain group. Participants underwent a clinical examination 
including measurement of maximum horizontal and vertical jaw excursions, and as 
well all participants completed the Depression, Anxiety and Stress Scale (DASS-21) 
and the Pain Catastrophizing Scale (PCS). Pain intensity was maintained at a 
moderate (40-60/100 mm) level throughout the continuous infusion period. The mean 
velocity and the mean amplitude of the outgoing (i.e. opening) and return (i.e. closing) 
phases of the chewing cycles were analyzed using a mixed model Analysis of 
Variance (ANOVA) where block (Baseline, Block 1, Block 2 and Block 3) was the within 
subject factor and group (experimental pain and control) was the between subject 
factor. The data was analyzed for main effects of block and for interaction between 
block and group. The analyses were undertaken separately for each of the outgoing 
and closing phases for each of the free chewing movement and the standardized 
chewing movement. 
Results: There were no significant differences (p>0.05) between the experimental 
pain and control groups for age, measurements of maximum jaw opening, for the 
total score of the (PCS) or for the scores of depression, anxiety or stress.  
During free chewing, statistical analyses of the opening phase did not find a 
significant effect of Block on velocity and no significant interaction between the 
experimental pain and control groups and the 4 Blocks. For the closing phase there 
was a significant effect of Block (p = 0.00) but no significant interaction. For the 
amplitudes on both the outgoing and closing phases there was no significant effect 
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of Block and no significant interaction. During standardized chewing, for velocity and 
amplitude of the outgoing and closing phases, there was a significant effect of Block 
but no significant interaction.  
A general observation was that the amplitudes and velocities of both free and 
standardized chewing tended to be greater in the later blocks in both the 
experimental pain group and the control group. Variability of the amplitude velocity 
tended to be greater for the experimental pain group than for the control group. 
Conclusion: The findings of the present study show that in comparison with a 
matched control group, there were no significant effects of pain on the amplitude or 
velocity of jaw movement during chewing. The data showed that while there may be 
an increase in the amplitude and/or velocity of jaw movement during pain, these 
same effects occurred in the matched control group. The present findings therefore 
do not support the general hypothesis of this thesis that following a resolution of a 
brief episode of orofacial pain, there are significant changes in jaw motor activity that 
persist beyond the period of pain. 
Keywords: Jaw movement, Orofacial pain, Hypertonic saline, jaw muscle activity, 
chewing, pain adaptation model, vicious cycle theory 
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Introduction: 
Pain is considered to have an effect on muscle activity and movement and although 
there has been much research as to these effects, controversy still exists as to the 
nature of the association. Pain is a symptom of TMD which are a group of conditions 
characterized by pain and dysfunction in the jaw joint and the muscles that control 
jaw movement. About 10% of TMD patients progress to chronic pain and disability 
and it is unclear why some patients progress to chronic TMD whiles others do not. 
Genetic factors and deficiencies in central pain modulatory systems have been 
implicated as possible reasons. Another factor that might contribute to the transition 
from acute to chronic TMD pain is that the jaw motor system may develop a new 
pattern of jaw movement and muscle activity in some individuals who experience an 
acute episode of jaw muscle pain and this new pattern may actually generate more 
pain. 
Recent studies in both animals and humans have shown that both experimental and 
clinical pain may be associated with changes in jaw movement and jaw muscle 
activity. In general terms, clinical or experimental pain can result in smaller and 
slower movements than asymptomatic controls (Svensson et al 2001; Murray and 
Peck 2007; Akhter et al 2014). There is also evidence that changes in muscle 
activation can persist beyond the period of pain and these persistent effects of 
changes in muscle activity have been demonstrated in association with experimental 
low back pain or experimental knee pain (Hodges and Tucker, 2011). Further, it has 
been proposed in the spinal system (Hodges and Moseley 2003) that some of these 
persistent changes in muscle activity might contribute to a recurrence of signs and 
symptoms in some individuals.  
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In the jaw motor system, there is much less information about possible persistent 
effects, although there are some data available. For example, the linear 
electromyogram – force relationship was shown to be less steep on the painful side 
during and immediately after 15 mins of muscle pain induced by a hypertonic saline 
infusion into the masseter muscle (Wang et al 2002).  
There is also a good evidence for neuroplastic changes within the brain in 
association with learning as well as with changes to the oral environment including 
pain (Avivi-Arber et al 2011). For example, in the anaesthetized rat, noxious 
stimulation of the tongue resulted in a prolonged decrease in the excitability of the 
face region of the primary motor cortex (Adachi et al 2008) and similar inhibitory 
effects that outlast the period of the noxious stimulation have been demonstrated in 
humans (Nash et al 2010). These effects of noxious stimuli on the motor cortex may 
be selective and only decrease the excitability of those motor cortical regions driving 
muscles in close vicinity of the noxious stimulus (Adachi et al 2008). Therefore, 
noxious stimuli may lead to a reorganization of the activation of the motor cortex to 
allow the motor cortex to function despite the presence of the noxious stimuli. The 
reorganization of motor cortical activity that may be occurring in pain may lead to a 
reorganization of motor unit recruitment patterns in pain and this has been recently 
proposed in new models of pain-motor interaction (Tucker and Hodges 2010; Murray 
and Peck 2007). One of these newer models also implicates psychological factors in 
this pain-motor interaction and there indeed is some evidence that psychological 
factors, such as pain catastrophizing may play a role in this transition from acute to 
chronic pain (Kalso et al 2000). 
Therefore, the neuroplastic changes that might be occurring in association with 
orofacial pain, possibly influenced by some psychological factors, might lead to 
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changes in jaw motor activity that may possibly predispose an individual to a return 
of symptoms. The general hypothesis of this thesis therefore is that following a 
resolution of a brief episode of orofacial pain, there are significant changes in jaw 
motor activity that persist beyond the period of pain. 
 The aims were: 
1. To determine whether a continuous infusion of hypertonic saline results in 
significant changes in jaw movement velocity and amplitude during chewing in 
comparison with control. 
2. To investigate whether a continuous infusion of hypertonic saline results in 
significant changes in jaw movement velocity and amplitude during chewing in 
comparison with control and which are apparent after the resolution of the pain 
following cessation of the infusion of hypertonic saline. 
The first specific hypothesis is that a continuous infusion of hypertonic saline into the 
masseter muscle results in an experience of moderate pain in healthy individuals 
and this infusion leads to significant reductions in jaw movement amplitude and 
velocity of chewing in comparison with a control group. The second specific 
hypothesis is that a continuous infusion of hypertonic saline results in significant 
changes in jaw movement velocity and amplitude during chewing in comparison with 
control that are apparent after the resolution of the pain following cessation of the 
infusion of hypertonic saline. 
It is considered that data addressing these issues may lead to improved 
understanding as to whether a past experience of pain may alter motor control and 
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which might predispose to recurrence of pain and contribute to the transition from 
acute to chronic pain. 
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Mechanisms of Pain 
Pain is defined by the International Association for the study of Pain (IASP) as “an 
unpleasant sensory and emotional experience associated with actual or potential 
tissue damage, or described in terms of such damage’’( Merskey and Bogduk 1994). 
Acute pain is a type of pain that typically lasts less than 3 to 6 months, or pain that 
is directly related to soft tissue damage such as a sprained ankle or a paper cut. 
Acute pain is of short duration but it gradually resolves as the injured tissues heal. 
Chronic pain is often defined as any pain lasting more than 3 to 6 months. Whereas 
acute pain is a normal sensation that alerts us to possible injury, chronic pain is very 
different. Chronic pain persists for months or years and has no clear biological value.  
Acute pain is provoked by a specific disease or injury and most dental practices 
manage acute dental pain very well. The cause of acute pain is usually clear and in 
many cases can be readily treated. Chronic orofacial pain, in contrast may be 
considered as a diseased state (Sessle et al 2005). It normally outlasts the healing 
period and is associated with psychological manifestations, such as depression and 
anxiety. The cause of chronic pain is often unclear and therefore chronic pain is 
usually difficult to treat (Grichnik et al 1991).  
About 10% of TMD patients progress to chronic pain and disability from the acute 
state and it is unclear why some patients progress to chronic TMD whiles others do 
not (Velly et al 2011). Genetic factors and deficiencies in central pain modulatory 
systems have been implicated as possible factors that contribute to the transition 
from acute to chronic pain. Other factors have also been implicated such as long-
term changes in motor control features that may arise because of the pain but the 
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changes persist after the resolution of the pain. These changes may lead to a 
recurrence of symptoms. 
Peripheral nociceptive pathways 
Pain is a vital function of the nervous system in that it provides the body with a 
warning of potential or actual injury. Pain is both a sensory and emotional 
experience, and is affected by psychological factors such as past experiences, 
beliefs about pain and fear or anxiety. Nociceptive information about orofacial pain, 
which is information about a noxious stimulus from the intra-oral and extra-oral 
structures of the head and face, is carried to the central nervous system via the 
trigeminal system. The trigeminal nerve is a mixed nerve containing both sensory 
and motor fibers. The trigeminal sensory fibers innervate the anterior part of the face, 
teeth, and mucous membranes of the oral and nasal cavities and sinuses, as well as 
muscles and joints. 
Somatosensory information from the face and mouth is carried by primary afferent 
neurons through the trigeminal ganglion to synapse with second order neurons in the 
trigeminal brain stem sensory nuclear complex. Somatosensory nerve cells that 
innervate peripheral tissues are termed primary afferent neurons and are of many 
types. Nociceptors are the specialized sensory receptors responsible for the detection 
of noxious (painful or potentially painful) stimuli, transforming the stimuli into action 
potentials, which are then conducted to the central nervous system. The free nerve 
endings of primary afferent fibers are Aδ and C fibers. The Aδ nociceptive afferent 
fibers are thinly myelinated, while the C fibers are unmyelinated fibers. Distributed 
throughout the body (e.g. skin, viscera, muscles, joints, meninges), they can be 
stimulated by mechanical, thermal or chemical stimuli. Receptors responsive to tactile 
17 
 
sensation are called low-threshold mechanoreceptors. In general, there are 2 types of 
pain: fast pain and slow pain. Fast pain is also known as sharp pain, pricking pain or 
acute pain, and is easily localized and not felt in the deep visceral organs and the 
responsible nociceptive pathways involve the Aδ fibers. Slow pain is also known as 
throbbing pain or aching pain, and it can occur both in the skin and in almost any deep 
tissue or organ, and the responsible nociceptive pathways involve the C fibers. 
After tissue injury, nociceptors can undergo peripheral sensitization which 
contributes to altered sensations such as hyperalgesia and allodynia (Marchand et al 
2005). Hyperalgesia is increased pain to a painful stimulus, whereas allodynia is the 
presence of pain to a non-noxious stimulus. This peripheral sensitization process 
comes about because of the release of mediators from immune cells in the vicinity of 
the injured tissue and these mediators sensitize the nociceptive terminals so that the 
person may feel pain in response to light tactile stimuli.  
Central nociceptive pathways 
The trigeminal brain stem sensory nuclear complex (Figure 1) is divided into the 
mesencephalic nucleus of the trigeminal nerve, the principal sensory nucleus and 
the spinal tract nucleus. The spinal tract nucleus is divided into the following 
subnuclei: caudalis, oralis, and interpolaris (Figure 1). The subnucleus caudalis is 
involved in the transmission of temperature and nociceptive information from the 
orofacial area to higher centers of the brain (Figure 1). In addition, there are non–
nociceptive neurons within the trigeminal brain stem sensory nuclear complex that 
are called low-threshold mechanoreceptive neurons and they convey information 
about non-noxious stimuli. The convergence of many afferent inputs to the trigeminal 
brain stem sensory nuclear complex, and indeed onto any one second order neuron, 
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is one reason why the brain may be unable to detect the exact source of a noxious 
stimulus in the orofacial area. Convergence may also be responsible for referred 
pain. Some of the neurons within the trigeminal brain stem sensory nuclear complex 
give rise to axons which pass out in the trigeminothalamic tract and synapse with 
third order neurons in the thalamus (Conti et al. 2003). These nociceptive and non-
nociceptive neurons within the thalamus can send axons to higher centers including 
the primary and secondary somatosensory cortical regions for the sensory-
discriminative aspects of pain and also the insula, anterior cingulate cortex and 
prefrontal cortex for the emotional processing of nociceptive information (Sessle et al 
2008). There are two basic types of nociceptive neurons in the trigeminal brain stem 
sensory nuclear complex: the nociceptive specific and the wide dynamic range 
neurons. These neurons are also present in the thalamus and primary 
somatosensory cortical region (Sessle et al 2008). 
Brainstem pathways: 
Each component of the trigeminal brain stem sensory nuclear complex contains 
thousands of neurons, as well as nerve fibers that represent the collaterals of the 
incoming primary afferents and fibers derived from other brainstem sites. The 
neurons in the trigeminal brain stem sensory nuclear complex are somatotopically 
arranged. The dorsal part of each of its nuclei or subnuclei is mainly comprised of 
neurons with a receptive field in the craniofacial region and is supplied by the 
mandibular branch of the V nerve. The ventral part contains neurons with an 
ophthalmic innervation, and the area in between the dorsal and ventral parts 
represents the maxillary region. The oral and peri-oral structures are usually 
represented medially. The brainstem projections of fibers and neurons in each of the 
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various components of the VBSNC contribute to ascending somatosensory 
pathways to higher brain centers such as the thalamus.  
Some of the neuronal connections in the brainstem are for reflex effects and these 
have been extensively studied in both experimental animals and humans (Sessle 
2000). Most of these studies have focused on the jaw muscles and have used brief 
stimuli. These stimuli typically produce excitatory reflex effects in the jaw-opening 
muscles and inhibitory effects in the jaw-closing muscles (Sessle 2000). 
 
20 
 
 
              (Reproduced from Sessle 2006) 
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Pain modulation and perception  
The human nervous system has an ability to alter the intensity of nociceptive signals 
that ascend to higher centres and thereby to alter the pain experience. Signals from 
higher centres of the brain such as the limbic system travel along neural pathways 
that descend to the brainstem and spinal cord to reduce the transmission of 
information from the primary afferent nerves onto second order neurons. This 
modulation takes place within the spinal trigeminal nucleus (Sessle 1986; Conti et al 
2003). 
After transmission and modulation of the nociceptive signals to higher centres of the 
brain, pain is perceived through the integrated processing of nociceptive information 
within the different regions of the brain.  
Functional jaw movements 
Human jaw movement is very complex and it results from the combined activity of 
the masticatory muscles. The following provides a brief summary about the 
Temporomandibular Joint (TMJ) and the muscles of mastication. 
The movements of the TMJ are complex. There are two synovial cavities. The 
articular disc is a plate of dense fibrous tissue which divides the TMJ into upper and 
lower cavities. The upper cavity is the joint between the disc and the mandibular 
fossa and allows a gliding movement in both an anterior direction (protrusion) onto 
the articular tubercle (or eminence) and posteriorly (retraction). The lower cavity is 
the joint between the disc and the condylar head of the mandible and it is tighter, and 
allows a hinge movement that allows depression or elevation of the mandible. 
(Christo et al 2005). The disc also can be divided into three regions based on its 
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thickness: the anterior thick, the intermediate thin zone and the posterior thick zone. 
There is fourth part of the disc which is called as bilaminar zone. This zone contains 
dense collagen fibers. Lateral movements are a mixture of protrusion (anterior 
gliding) on one side with retraction (posterior gliding) on the other side, so using the 
upper joints. The space between the two laminae and the posterior part contains 
loose connective tissue (Christo et al  2005). A fibrous capsule is attached to the 
articular area on the temporal bone and also around the neck of the mandible. 
Laterally, it is thickened to form a lateral ligament. The two types of ligament namely, 
sphenomandibular ligament and stylomandibular ligament also connect the mandible 
to the skull, where they provide stability of the joint. 
The Masseter muscle 
The masseter is a thick quadrate multipennate muscle that covers the lateral aspect 
of the ramus and coronoid process of the mandible. It helps in elevating and 
protruding the mandible. There are several heads. The superficial head arises from 
the anterior two thirds of the lower border of the zygomatic arch and inserts to the 
angle of the mandible and ramus. The middle head arises from the zygomatic arch 
and the deep head from the deep surface of the arch. Both the middle and deep 
head inserts into the coronoid process (Hannam and McMillan 1994). The superficial 
fibers are initiated during jaw elevation, protrusion and lateral movement. Retrusion 
and elevation is provided by the deep fibers. 
Temporalis muscle 
This muscle is fan shaped and it arises from the temporal fossa and laterally from 
the temporal fascia. Both anterior and posterior fibers converge to form a flat tendon 
and it inserts into the coronoid process of the mandible as well as the ramus 
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(Hannam and McMillan 1994). This muscle helps in elevation of mandible and its 
posterior fibers play a role in retraction of the mandible (Cunningham and Romanes 
1986). 
Lateral pterygoid muscle 
This muscle is considered to have two heads. The superior head arises from the 
infratemporal crest and also from infratemporal fossa, while the inferior head arises 
from the lateral surface of the lateral pterygoid plate. The muscle inserts into the 
fovea of the mandibular condyle and the articular disc-capsule complex of the TMJ. 
Both superior and inferior heads play a role in jaw opening, jaw protrusion and 
contralateral movements (Phanachet et al 2001; Phanachet et al 2003; Ruangsri et 
al 2005). 
Medial Pterygoid muscle 
The medial pterygoid is a bulky muscle that arises from the pterygoid fossa. The 
muscle has two heads which covers the lateral pterygoid muscle. The superior head 
arises from the maxillary tuberosity and palatine bone. The deep head arises from 
the medial surface of the lateral pterygoid plate. The two heads run deeply and insert 
onto the medial surface of the ramus of the mandible. This muscle helps in elevation, 
protrusion, contralateral movement. This muscle also provides grinding movement. 
Neural control of jaw movements 
Chewing is controlled and generated by a central pattern generator (CPG) which is a 
group of neurons that is located in the hindbrain and medulla (Lund and Kolta 2006). 
The output of the CPG is influenced by the higher centers of the brain and sensory 
feedback from receptors in the orofacial region such as muscle spindles and 
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receptors within the periodontal ligament. The jaw movement pattern differs from 
person to person. The jaw movement pattern is also influenced by factors such as 
age, gender, or type of food. For example, chewing harder gum in comparison to 
chewing softer gum results in differences in both opening and closing phases of the 
chewing cycle (Woda et al 2004). 
Effects of pain on jaw movement and activity  
Orofacial pain can affect jaw motor functions such as chewing and talking. From the 
clinical perspective, the symptoms of TMD especially appear to have effect on jaw 
motor activities. The precise relationship between pain and motor function is 
however not entirely clear and has been a subject of controversy for many years. As 
a result, there have been many studies of the effects of pain on motor activity not 
only in the trigeminal motor system (for review, Murray and Peck 2007), but also in 
the spinal motor system (for review, Hodges and Tucker 2011). In terms of the 
effects of orofacial pain on jaw motor activity, some studies have shown reductions 
in movement during experimental or clinical pain while others do not.  
In one study (Sae-lee et al 2008), hypertonic saline injections were injected into the 
masseter muscle and demonstrated that, in comparison with control isotonic saline 
injections, there were no significant effects on the amplitude or velocity of protrusive 
or contralateral jaw movements and no significant effects on the velocity of jaw 
opening movements. However, hypertonic saline injections resulted in significant 
reductions in jaw opening amplitude. This study also showed that during free 
chewing, subjects chewed faster and exhibited larger amplitude gapes both 
hypertonic saline and isotonic saline infusion in comparison with control. There were 
no significant differences between hypertonic saline and isotonic saline infusion 
during standardized chewing. One possibility that might explain the absence of 
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significant differences between the hypertonic saline and isotonic saline infusion 
conditions, is that there may be persistent effects of a previous experience of pain 
(e.g. Hypertonic saline infusion) on subsequent experimental trials (e.g. isotonic 
saline infusion). Another factor to consider is the possible role of practice effects or 
the motivation to finish the experiment, on jaw movement over time. 
Models explaining the relation between pain on jaw motor activity  
Various theories have been put forward in an attempt to explain the interaction 
between pain and motor activity. The topic has been reviewed both for the trigeminal 
and spinal systems (Murray and Lavigne 2014; Murray et al. 2014; van Dieen et al 
2004; Svensson and Graven-Nielsen 2001; Murray and Peck 2007). 
 
Vicious cycle theory 
The vicious cycle theory is also known as the pain–spasm-pain theory, and it refers 
to the view that chronic muscle pain has a strong association with muscle 
hyperactivity at rest and also during function (Travell 1942). The theory states that 
aggravating and/or initiating factors such as abnormal posture, movement, or stress, 
lead to pain which then via reflex action leads to muscle hyperactivity which then 
leads to further pain. A vicious cycle is set up that contributes to spasm or fatigue 
and thereby pain and dysfunction (Travell et al 1942). Evidence for and against this 
model has been reviewed (Murray and Peck 2007; van Dieen et al 2003). While 
there is some evidence in support of the model, there is much evidence that does 
not support the model. For example, while some studies show an increase in EMG 
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activity at rest during pain, these increases are small and other studies show no 
change or even a decrease in EMG activity (for review, Murray and Peck 2007).  
One mechanism whereby the Vicious Cycle Theory is thought to operate is through 
the gamma–motoneuron innervation of muscle spindles (Johansson and Sonja 
1991). In this, local inflammatory mediators activate muscle nociceptive afferents 
which excite gamma-motoneurons and thereby decrease the fidelity of spindle 
afferent transmission. This loss of proprioceptive acuity may lead to a less efficient 
muscular coordination and a greater accumulation of metabolites and thereby more 
pain (reviewed in Murray and Peck 2007).  
 
 
Pain Adaptation Model 
This model proposes that pain results in alterations in muscle activity that limits 
movement. Also, this theory provides an explanation of adaptive mechanisms in the 
motor system in preventing further injury and promoting healing (Lund et al 1991). 
This model proposes that existing pain will act through segmental mechanisms and 
will result in a reduction of jaw motor and jaw muscle activity. This theory proposes a 
decrease in agonist muscle activity in pain, and an increase in antagonist muscle 
activity that acts to resist an action. These electromyographic effects may explain the 
slower and smaller movements, occurring in pain, that act to minimize further injury 
and therefore aid in healing. The skeletomotor system is therefore protected from 
further damage. This model explains how the pain effects act as a protective 
mechanism and the effects are not a cause of the pain.  
27 
 
Evidence for and against this model has been reviewed (Murray and Peck 2007; van 
Dieen et al 2003). There is much evidence in support of this model, for example, 
experimentally – induced pain caused by infusion of hypertonic saline into the 
masseter muscle resulted in decreased EMG activity of the jaw closing muscles in 
the agonist phase and increased EMG activity in antagonist phase during chewing 
(Svensson et al 1997).  
However, there is also some evidence that is not consistent with the model. For 
example, while some studies do show a decrease in agonist EMG activity and an 
increase in antagonist EMG activity during pain, other studies do not show such 
effects (for review, Murray and Peck 2007; Some of the data support the view that 
the effects of pain on EMG activity or jaw movement vary with the task being 
performed (Sae-Lee et al 2008a, b).  
Integrated Pain Adaptation Model: 
A possible reason for the inconsistent findings between various studies that have 
investigated the Vicious Cycle theory and the Pain Adaptation model could reflect 
the complexity of the pain-motor interaction. More recently, the Integrated Pain 
Adaptation Model (IPAM) has been proposed (Murray and Peck 2007; Murray and 
Lavigne 2014). According to this model, there is a new activation pattern of the motor 
system in the presence of pain. This new pattern of activation is influenced by the 
sensory-discriminative, motivational-affective and cognitive aspects of pain. The 
resultant effect of these changes is to lead to homeostasis. This model also 
proposes that the changes in motor activity can arise through changes in activity at 
any level of the motor system, instead of only at the level of the brain stem where the 
Pain Adaptation Model and Vicious Cycle Theory have been proposed to operate. 
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Recently, a new theory of motor adaptation to pain has been proposed (Hodges and 
Tucker 2011) which states that pain causes changes at multiple levels of the nervous 
system. This model also proposes that the resulting changes in muscle activity may 
provide short-term protection to the motor system but may result in long-term 
negative outcomes and one possibility is the alteration of mechanical behavior that 
may predispose to a recurrence of symptoms (Hodges and Tucker 2011). These 
proposals are suggestive of possible long-term consequences following exposure to 
painful stimuli. 
 
Pain Catastrophizing and the Fear Avoidance Model  
Another model that has received considerable attention in recent years is the fear 
avoidance model. This model explains how acute pain can progress to the chronic 
condition. Patients with low fear of pain are likely to have functional activities 
resulting in recovery of pain. In contrast, the model proposes that individuals who 
catastrophize about their pain leads to having greater fear of pain and thereby 
avoidance of activity involving the painful part. This high fear of pain leads to a cycle 
of fear of pain, disuse /disability and reduction in pain threshold (Vlaeyen and Linton 
2000). Pain catastrophizing is a multidimensional factor and consists of rumination, 
magnification and helplessness (Osman et al 1989). There is also increasing 
evidence that fear of pain may cause more disability (Crombez et al 1999). This 
model highlights the importance of psychological factors in the transition from acute 
to chronic pain, and underscore the increasing acceptance that psychological factor 
plays an essential role in transition from acute to chronic pain and disability in regard 
to TMD. 
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High–catastrophizing individuals have a tendency to focus on the pain sensation and 
to experience a sense of helplessness. There have been a number of studies 
providing data that are consistent with the fear avoidance model in the spinal 
literature. Patients with chronic pain have impaired performance on a variety of tasks 
(Thomas et al 2008). Further, individuals with high pain-related fear exhibit restricted 
movement and are at greater risk of pain and re-injury (Thomas and France 2007). 
Therefore, this model may help in the explanation of the transition from acute to 
chronic TMD and may also contribute to our understanding the other orofacial pain 
states. 
Subjects who have high pain-related fear have high pain compared to those with low 
pain-related fear even after resolution of back pain (Thomas and France 2007). 
There is a possibility that individuals with higher pain-related fear will continue to 
restrict their movement and will be at greater risk of pain and re-injury (Leeuw at al 
2007). If it is possible to determine how the motor system is altered after an episode 
of pain, we may be able to define improved treatment options as well as an 
opportunity to prevent the transition from acute to chronic pain. 
There is evidence showing catastrophizing leads to increase psychological and 
functional disability in patients with chronic pain and spinal cord injury (Leeuw et al 
2007). Also, neuropathic pain patients who are disabled showed high catastrophizing 
scores. Similarly, there are data providing evidence that patients with moderate to 
high TMD pain have a relation with depression and non-masticatory jaw activity 
limitations (Leeuw et al 2007). There is also similar evidence that subjects with 
chronic low back pain are more likely to have more fear with increased avoidance 
behavior (Vlaeyen et al 1995). Further, subjects with high pain catastrophizing have 
been shown to be significantly associated with increased activity in brain areas 
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related to the attention and emotional aspects of pain, but not in brain regions 
associated with the sensory-discriminative aspects of pain (Sessle et al 2008). 
There is also recent evidence that psychological variables influence the relation 
between pain and motor activity (Leeuw et al 2007; Brandini et al 2011). For 
example, patients who had recently recovered from low back pain but who had 
higher pain–related fear, had smaller peak velocity and acceleration of their spine 
and hip compared to those with low pain-related fear (Thomas et al  2008). It is 
possible that patients with high pain-related fear may modify their movement pattern 
or avoid movement in an attempt to prevent relapse of pain and re-injury during 
function but these individuals who continue to restrict their movement may be at a 
greater risk of pain and re-injury (Thomas and France 2007). 
 
All this provides evidence that catastrophizing plays an important role in pain. Higher 
pain catastrophizing individuals may exhibit a greater central nervous system (CNS) 
sensitization during pain that may involve enhanced activity in higher centres (e.g. 
prefrontal cortex) and this may influence the interpretation of information from 
nociceptive pathways (Edwards et al 2000). Thus there is an association between 
pain catastrophizing and exaggerated hypothalamic-pituitary-adrenocortical activity 
(Quartana et al 2010). This might help explain changes in peripheral sensitization.  
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Transition from acute to chronic pain: possible role for persistent motor 
effects 
Most patients who undergo surgery recover uneventfully and resume their normal 
daily activities within weeks. The exact mechanism of acute pain in transition to 
chronic pain is not known (Voscopoulos  et al 2010). The transition from acute to 
chronic pain appears to occur in discrete pathophysiological and histopathological 
steps. Persistent, intense pain, however, activates secondary mechanisms both at 
the periphery and within the central nervous system that cause allodynia and 
hyperalgesia that can diminish normal functioning. The question of whether acute 
pain causes chronic pain has not been completely resolved, but some type of 
stimulus or continuous nociceptive process provides the impetus for chronic pain to 
develop. The mechanisms are multifactorial and complex (Chapman et al 2008). 
Stimuli initiating a nociceptive response vary, but receptors and endogenous defence 
mechanisms in the periphery interact in a similar manner regardless of the insult. 
Chemical, mechanical, and thermal receptors, along with leucocytes and 
macrophages, determine the intensity, location, and duration of noxious events. 
Noxious stimuli are transduced into action potentials and the resultant actions by the 
individual involve sensory-discriminative, motivational-affective, and modulatory 
processes in an attempt to limit or stop the painful process. Under normal conditions, 
noxious stimuli diminish as healing progresses and pain sensation lessens until 
minimal or no pain is detected. Persistent, intense pain, however, activates 
secondary mechanisms both at the periphery and within the central nervous system 
that cause allodynia, hyperalgesia, and hyperpathia that can diminish normal 
functioning (Hunt et al 2001).These changes begin in the periphery with upregulation 
of cyclo-oxygenase-2 and interleukin-1β-sensitizing first-order neurons, which 
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eventually sensitize second-order spinal neurons by activating N-methyl-D-aspartic 
acid channels and signaling microglia to alter neuronal cytoarchitecture. Throughout 
these processes, prostaglandins, endocannabinoids, ion-specific channels, and 
scavenger cells all play a key role in the transformation of acute to chronic pain. A 
better understanding of the interplay among these substances will assist in the 
development of agents designed to ameliorate or reverse chronic pain (Harstall et al 
2003). 
A number of predictors of chronicity in low back pain are  
1. Pain predictors where earlier literature categorizes these predictors into three 
levels, primary or preinjury, secondary or pre-chronicity and tertiary or chronic 
outcome predictors. The literature in recent times has pointed to psychological 
factors as being clearly associated with the development of chronicity. 
(Alschuler et al 2005).  
2. Disease related factors in which few associations have been identified 
between the disease related factors and chronicity.  
3. Occupational factors contribute significantly to the risk of chronicity. Workers 
with sub-acute low back pain and receiving worker’s compensation, reported 
that stress, fear and beliefs about work correlated strongly with progression to 
chronicity. 
4. Psychological factors which have an adverse bearing on prognosis have been 
identified in most studies as having a stronger influence on outcome than 
conventional clinical information. The way people "deal with the demands and 
challenges of everyday life" in a number of studies ( Stanley  2006) these has 
been reported to be associated with development of chronicity.  
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5. The combination of sensory – discriminative, cognitive, motivational features 
and psychological factors involve both in emotions and cognitions. This shows 
patients with chronic pain are at increased risk of emotional factors (Schmerz 
et al 2010).  
There is also evidence that changes in muscle activation can persist beyond the 
period of pain and these persistent effects of changes in muscle activity have been 
demonstrated in association with experimental low back pain or experimental knee 
pain (Hodges and Tucker 2011). Further, it has been proposed in the spinal system 
(Hodges and Moseley 2003) that some of these persistent changes in muscle activity 
might contribute to a recurrence of signs and symptoms in some individuals.  
Various studies show that changes in postural adjustment of the trunk muscle that 
occur during pain are not caused by pain, but may be due to the development and 
adaptation of an alternate movement strategy. This clearly explains that in low back 
pain, postural adjustments of the trunk muscles are altered. The data suggest that 
long-term postural changes may pose a risk to spinal cord structures and may lead 
to chronic problems (Moseley and Hodges 2007). 
There is also evidence that patients with low back pain show evidence of changes in 
control of trunk movements and changes within the central nervous system (Thomas 
et al 2008). These changes and alterations are reversible when the symptoms are 
relieved (Chiou et al 2015). These studies show that subjects who recovered from 
previous back pain episodes have the same level of neural drive and cortical spinal 
stability which are similar to healthy subjects. Hence more research is required to 
assess whether pain persists beyond the injury and whether it has any effect on the 
movement. 
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In the jaw motor system there is much less information about possible persistent 
effects. For example, the linear electromyogram – force relationship was shown to 
be less steep on the painful side during and immediately after 15 mins of muscle 
pain induced by a hypertonic saline infusion into the masseter muscle (Wang et al 
2002). Recently, there is evidence from an exploratory pilot study implicating 
possible long-term effects of pain on motor control and that catastrophizing might 
play a role in these effects (Bhaskaracharya et al 2015). In this study of jaw 
movements in pain-free patients with a history of neuropathic pain, there was 
significantly increased variability in jaw movements during chewing in comparison 
with controls (p<0.05, Levene’s test), and significant (p<0.05) negative correlations 
between pain catastrophizing scores and velocity and amplitude of chewing 
(Bhaskaracharya et al 2015).  
There is also a good evidence for neuroplastic changes within the brain in 
association with learning as well as with changes to the oral environment including 
pain (Avivi-Arber et al 2011). For example, in the anaesthetized rat, noxious 
stimulation of the tongue resulted in a prolonged decrease in the excitability of the 
face region of the primary motor cortex (Adachi et al 2008) and similar inhibitory 
effects have been demonstrated in humans (Nash et al 2010). 
These effects of noxious stimuli on the motor cortex may be selective and only 
decrease the excitability of those motor cortical regions driving muscles in close 
vicinity of the noxious stimulus (Adachi et al 2008). Therefore, noxious stimuli may 
lead to a reorganization of the activation of the motor cortex to allow the motor cortex 
to function despite the presence of the noxious stimuli. The reorganization of motor 
cortical activity that may be occurring in pain may lead to a reorganization of motor 
unit recruitment patterns in pain and this has been recently proposed in new models 
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of pain-motor interaction (Tucker and Hodges 2010; Murray and Peck 2007). One of 
these newer models also implicate psychological factors in this pain-motor 
interaction and there indeed is some evidence that psychological factors, such as 
pain catastrophizing may play a role in this transition from acute to chronic pain 
(Leeuw et al 2000). Therefore, the neuroplastic changes that might be occurring in 
association with orofacial pain, possibly influenced by some psychological factors, 
might lead to changes in jaw motor activity that may possibly predispose an 
individual to a return of symptoms.  
 
 
Summary 
The above review describes the motor effects of orofacial pain on jaw motor activity. 
The effect of pain on movement still remains controversial and a number of theories 
and models have been proposed to explain the interaction. The factors that 
contribute to the transition from acute to chronic pain are still unclear. There is some 
evidence in the spinal literature that changes in muscle activation in association with 
pain can persist beyond the period of pain (Hodges and Tucker 2011; Hodges et al 
2003). These changes may contribute to the recurrence of pain. There is much less 
information in the jaw motor system on the possibility of persistent motor effects after 
an episode of pain. However, there is some preliminary evidence that pain can 
induce persistent motor effects in the jaw motor system (Adachi et al 2008; Nash et 
al 2010; Bhaskaryacharya et al 2015).  
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The general hypothesis of this thesis therefore is that following a resolution of a brief 
episode of orofacial pain, there are significant changes in jaw motor activity that 
persist beyond the period of pain. 
 
 
The aims were: 
1. To determine whether a continuous infusion of hypertonic saline results in 
significant changes in jaw movement velocity and amplitude during chewing in 
comparison with control.  
2. To investigate whether a continuous infusion of hypertonic saline results in 
significant changes in jaw movement velocity and amplitude during chewing in 
comparison with control that are apparent after the resolution of the pain 
following cessation of the infusion of hypertonic saline. 
The first specific hypothesis was that a continuous infusion of hypertonic saline into 
the masseter muscle resulted in an experience of moderate pain in healthy 
individuals and this infusion led to significant reductions in jaw movement amplitude 
and velocity of chewing in comparison with a control group. The second specific 
hypothesis was that continuous infusion of hypertonic saline resulted in significant 
changes in jaw movement velocity and amplitude during chewing in comparison with 
control that apparent after the resolution of the pain following cessation of the 
infusion of hypertonic saline.  
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Chapter 2 Materials and Methods 
The study was a mixed design consisting of a between factor, that is, 2 groups and a 
within-participant factor, that is, 4 repetitions of the same tasks at given time points. 
 
2.1 Participants 
Twenty healthy pain free adults were recruited to participate in the study, of which 10 
participants were assigned to the experimental pain group and 10 participants to the 
control group. The participants were recruited from students and staff of the University 
of Sydney and the general public.  
Inclusion criteria for all of the participants were between the ages of 18-60 years and 
that they did not have a positive diagnosis of TMD or have pain in any part of their 
body at the time of the experiment. Each participant completed a screening 
questionnaire that asked about current and past medical conditions, hospitalization 
and current medications (Appendix 1). Participants were not invited into the study if 
they reported uncontrolled cardiovascular, hemorrhagic or respiratory disorders, a 
diagnosis of muscular skeletal pain disorders (e.g. Fibromyalgia, inflammatory joint 
disease), a systemic disease (e.g. lupus, malignancies), if they were being treated for 
a psychological disorder or were taking prescribed medications that might influence 
their response to pain. Participants were not randomly assigned. Most of the 
participants for the experimental pain group were recruited first and then control 
participants were recruited solely to match the age and gender distribution of the 
experimental pain group. No assessment was made of the menstrual cycle of any of 
the female participants. 
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The Western Sydney Local Health District and the University of Sydney Human Ethics 
Committees approved all experimental procedures. All subjects were given a detailed 
explanation of the procedure and gave written informed consent before participation. 
Experiments were conducted in the Jaw Function and Orofacial Pain Research Unit, 
Level 2, Westmead Centre for Oral Health, Westmead Hospital, Australia. 
 
2.2 Questionnaires 
When each participant was recruited, the Research Diagnostic Criteria for 
Temporomandibular Disorder (Dworkin and LeResche 1992) was used to verify the 
absence of signs and symptoms of TMD. A clinical examination (Appendix 2) was 
performed and the history questionnaire (Appendix 3) was completed to collect data, 
and determine the absence of a diagnosis. On the day of the experiment, the 
participant was given the PCS questionnaire (Appendix 4) ( Sullivan et al 1995) and 
the Depression, Anxiety and Stress Scales (Appendix 5) (Lovibond and Lovibond 
1995).The participant was then taken to the  recording room. See Figure 2.5 for the 
experimental procedure. 
 
2.2.1 Research Diagnostic Criteria for TMD (RDC/TMD)  
The RDC/TMD is considered the global gold standard to diagnose TMDs (Dworkin and 
LeResche 1992; Dworkin et al 1992) and uses a 2 axis concept of self-report and 
clinical signs and symptoms. The diagnoses can 1 or a multiple of 3 classifications, 
muscle pain with or without limited opening, bilateral or unilateral disk displacements 
and bilateral or unilateral joint disorders. Each participant entering the   two groups, 
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underwent the RDC/TMD assessment to verify the absence of signs and symptoms 
(Look et al 2010). The RDC/TMD involves a history questionnaire of past history of 
orofacial pain as well as a clinical examination including palpation of muscles and the 
TMJ, assessment of pain on movements, maximum jaw excursions and joint sounds. 
All participants in the current study were examined by a single calibrated examiner. 
 
2.2.2 The PCS  
Pain catastrophizing is the exaggerated negative belief about a painful experience 
(Leeuw et al 2007) which may influence the participant’s perception of pain intensity 
(Turner et al 2002; Akhter et al 2014). The PCS is a 13-statement questionnaire which 
asks the participant to rate on a 5-point Likert scale ranging from “not all” to “all the 
time” the degree to which each statement applies to them. The total score indicates 
the level of pain catastrophizing and has a ceiling score of 52. The PCS has been 
shown to have good internal consistency (Cronbach’s α = 0.87), test–retest reliability 
and construct validity (Osman et al 2000). The 13 statements represent 3 subsets of 
catastrophizing, that is, Rumination, Magnification and Helplessness. 
2.2.3 The Depression, Anxiety and Stress Scale-21 (DASS-21)  
The DASS-21 (Lovibond and Lovibond, 1996) is a reliable and well-validated measure 
of three psychological measures, depression, anxiety and stress. Participants are 
requested to rate the extent to which they had experienced each statement over the 
past week using a 4 point Likert scale ranging from 0 (Did not apply to me at all) to 4 
(Applied to me very much, or most of the time). Each of the three scales is represented 
by 7 items and the total scores for each scale consist of the sum of these items. 
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2.3 Jaw Movement Recording 
Jaw movement was recorded with an optoelectronic jaw tracking system (JAW2k 
system, Metroply AG, Zurich, Switzerland) with a sampling rate of 200 samples/s in 6 
degrees of freedom. The system consists of three charge – coupled device (CCD) 
cameras that record the position of 6 light-emitting diodes (LEDs) mounted on two 
target frames attached to the teeth via custom-made metal clutches. The movement 
of the mid-incisor point (MIPT, the point between the incisal edges of the lower central 
incisor teeth) represented mandibular movement and was displayed as a dot on a 
computer screen in front of the participant (Figure 2.1). 
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 Figure 2.1. Picture of a recording of a jaw movement showing the computer screen 
on which the target was tracked by the participant, the illuminated LED lights attached 
to the 2 target frames on the participant, and the optoelectronic cameras of JAW2k 
which tracked the movement. 
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43 
 
 
Figure 2.2. Picture of LED lights on target frames attached to metal clutches that are 
attached to upper and lower teeth. 
The custom-made clutches were temporarily attached to two to three upper and lower 
anterior teeth with cyanoacrylate adhesive and the other end of each clutch was 
connected to a target frame (Figure 2.2). Jaw movement was recorded in three 
dimensions and tracings of the movement were plotted along the x-axis (anterior-
posterior; posterior = negative), the y-axis (mediolateral; left = negative), and z-axis 
(superior-inferior; inferior = negative). In most participants, the clutches were 
constructed so as to provide minimal interference with lip seal but in some participants, 
the clutches did prevent proper lip seal. 
The participants were asked to chew a standardized pellet of gum until it was softened 
and then to chew on the right side only for a period of approximately 20 s. Each set of 
chewing cycles which lasted for approximately 20 s was called a trial. Two types of 
chewing movements were undertaken by the participant with each type of movement 
being repeated 3 times. The first type of chewing movement was a free chewing 
movement where the participants were asked to chew as normally as possible on the 
right side only. Figure 2.3 shows an example of the tracings of free chewing 
movements during a trial. 
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The second chewing movement was a goal-directed or standardised chewing 
movement. Figure 2.4 provides an example of a tracing of standardized chewing 
movements in a trial. The standardized chewing movement consisted of chewing the 
pellet of gum in time with a linear bank of target LEDS. The bank of LEDs oscillated at 
a rate of 900 ms which constituted 1 chewing cycle and were placed in front of the 
participant on a computer screen next to the computer tracing of the movement (Figure 
2.1). This visual feedback assisted the participant to chew at a standardized rate of 
movement within and between participants. Each set of 3 trials of free chewing and 3 
trials of standardized chewing was termed a block (that is, each block will be 6 trials). 
 
 
Figure 2.3. Example of a trial of free chewing movements. This display shows 
displacement of the mid-incisor point movement in the z-axis. The trial was 15 s in 
duration and the maximum amplitude was 16 mm. 
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Figure 2.4. Example of a trial of standardized chewing movements. This display 
shows displacement of the mid-incisor point movement in the z-axis. The trial was 15 
s in duration and the maximum amplitude was 15 mm. 
The rationale for selecting free chewing and standardized chewing is as follows. As 
described in the Introduction, free chewing is driven by a central pattern generator 
located in the brain stem with modulation of the activity by descending influences 
from higher centres (Lund and Kolta 2006). The standardized chewing movement, 
on the other hand, requires the participant to chew at a pre-determined rate and 
therefore, it is considered that there is a greater influence of higher centre controls 
on the chewing movement. The choice of these 2 types of chewing would provide an 
opportunity for an exploration of possible post-pain effects on motor activities that 
have a different mix of control mechanisms. Normal chewing was performed first and 
was not randomized between participants. This was not considered a major issue as 
all participants (in both control and pain groups) performed the tasks in the same 
sequence. 
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2.4 Jaw Muscle Activity Recording 
Jaw muscle activity was recorded from the bilateral anterior temporalis and masseter 
muscles and from the right digastric muscle with Ag/Ag-Cl surface electrodes 
(Duotrode, Myotonics, USA). A ground electrode was placed on the forearm. The 
electromyographic (EMG) signals were amplified and digitized with an isolated 
bioamplifier (World Precision Instruments, Florida) and stored on computer hard drive 
with the use of specialized data acquisition equipment and software (Spike3, 
Cambridge Electronic Design, Cambridge,UK). Muscle activity was sampled at a rate 
of 500 sample/s at a bandwidth of 100 Hz to 2.5 kHz for the surface electrode 
recordings. 
2.5 Experimental jaw muscle pain 
Experimental jaw muscle pain was induced by continuous infusion of 5% hypertonic 
saline into the right masseter muscle for a period of 10 minutes (see Figure 2.5). A 
disposable 24-gauge x 19 mm needle integrated IV catheter was inserted into the 
muscle, at least 1 cm away from the surface EMG electrode, and connected to an 
infusion pump (IVAC P 2000, IVAC Medical System, USA). After a bolus infusion of 
0.2 ml of hypertonic saline to rapidly increase pain intensity, hypertonic saline was 
continuously infused at a rate of 2 to 10 ml/hr.  A bolus infusion of 0.2 ml was attempted 
in every participant, but in some participant’s pain increased to the required range of 
40-60/100 mm after only 0.1 ml of infusion. At this time, infusion rate was reduced to 
a very low rate to maintain pain at the required range. The VAS was completed by 
each participant after every jaw movement trial, and these scores were used by one 
of the experimenters to make adjustments to the infusion rate after each trial so as to 
maintain a moderate (40-60/100 mm) level of pain intensity throughout the 10 minute 
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infusion period. There was considerably variability between individuals in the rate of 
infusion of hypertonic saline needed to achieve the required range of 40-60/100 mm. 
Therefore, the total volume infused between individuals varied considerably (see 
Results). 
Pain intensity was recorded on a 100-mm visual analogue scale (VAS) throughout the 
10 min infusion period, and for a further 10 minutes after (called washout period). The 
VAS is a straight line anchored at each end with words representing the participant’s 
perception of pain intensity, that is, “no pain” and “worst pain possible” (Appendix 6).  
After each trial, all participants also completed a pain map, which is an outline of the 
right and left side, and front and back of the head and on which the participant can 
indicate by drawing the location of their pain. A table indicating various intraoral 
positions, for example, left palate, was also provided to capture pain that may be 
referred to other sites inside the mouth (Appendix 6).  
2.6 Study Procedures 
At the start of the experiment, all participants were asked to complete the 
questionnaires after which they were moved to the recording room where they were 
shown the equipment. The participants were seated upright in a dental chair facing a 
computer screen and were reassured that they could withdraw from the experiment at 
any time. The surface electrodes were placed on the skin over each of the muscles 
that had been cleaned with alcohol to improve the recording. After electrode 
placement, the EMG signal from each electrode was tested for muscle activity from 
the intended muscle by asking participants to carry out simple jaw movements and 
isometric contractions. The EMG signals were also checked for low interference prior 
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to the recording. The metal clutches were then attached to the upper and lower teeth 
as previously described. 
All participants were then asked to complete a block of chewing movements, that is, 3 
free chewing and 3 standardized chewing trials, to provide baseline recordings, called 
Baseline in Figure 2.5. After which participants in the experimental pain group had a 
catheter inserted into the middle of the right masseter muscle that was then connected 
to the infusion pump. Hypertonic saline was infused over a 10-minute period. Each 
participant in this group was asked to complete a block of chewing movements, called 
Block 1 in Figure 2.5, as for the baseline recordings. During the hypertonic saline 
infusion, each participant scored pain intensity and outlined pain location maps after 
every chewing trial. The catheter was then removed from the right masseter muscle 
after which each participant completed pain intensity scales and pain location maps 
every minute for a minimum of 10 minutes and until all pain had subsided to 0/100 
mm. This period, called the washout period, was maintained until the participant 
indicated that they were no longer in pain. 
Participants in the control group carried out exactly the same block of chewing 
movements (Block 1 in Figure 2.5) except that there was no insertion of a catheter and 
no infusion of hypertonic saline into the masseter muscle. The control group also 
maintained a 10 minute washout period  
After this period, each participant was asked again to complete a block of chewing 
movements (Block 2 in Figure 2.5) the same as for the baseline. 
Both groups were then asked to rest for a further 5 minutes before being asked to 
complete a final block of chewing movements, called Block 3 in Figure 2.5, the same 
as for the baseline. After this final block of chewing movements had been completed, 
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the electrodes and the metal clutches were removed, and participant face and teeth 
were cleaned. Participants were asked if they had any questions and were thanked 
for their participation. 
 
2.7 Data analysis 
The data was analysed both qualitatively and quantitatively. Quantitative analyses was 
undertaken with statistical software SPSS (IBM SPSS Statistics 19, Chicago, USA) 
with a significance level of 0.05.  
Participant’s oral health history was analysed qualitatively to explore differences 
between the experimental pain and control groups. The age of the participants and the 
components of the clinical oral examination were analysed for differences between the 
groups using Independent t tests. 
The PCS questionnaire total score, subsets and total score quartiles were calculated 
according to the PCS User Manual (Sullivan 2009). Group differences between the 
total and subset scores were analysed using Independent t tests. Similarly, the DASS 
scale scores were analysed using Independent t tests to identify difference between 
the experimental pain and control groups. 
Within the experimental pain group, pain intensity VAS scores were calculated by 
measuring the location of the participant’s mark on the straight line. The difference 
between the intensity of the pain experience between the free chewing movement and 
the standardised chewing movement whilst being infused with hypertonic saline (Block 
1 in Figure 2.5) was analysed using a Paired t test. 
 Jaw movement was analysed using a customised computer program which identified 
the jaw opening and closing phases of each of the chewing cycles in each of the 
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movement trials. The distance the jaw moved from the most superior position of the 
mid-incisor point (that is, postural position) to the point where the participant changed 
the direction of the movement was considered the opening or opening phase of the 
chewing cycle. The closing or closing phase was considered to be at the end of the 
opening phase to the most superior position of the mid-incisor point (see Figures 2.3 
and 2.4). Each jaw movement trial was visually inspected and data affected by artefact 
was removed after which the velocity and amplitude of each of the outgoing and 
closing phases of each of the chewing cycles was calculated. 
The velocity, which was the speed at which the participant moved their jaw during the 
outgoing or closing phases, was calculated for each cycle within a block of free 
chewing movements for each participant. From this data, a mean velocity was 
calculated for each participant for each block of movements. For example, each 
participant had a mean velocity for the opening phase for Baseline, Block 1, Block 2 
and Block 3, and the same for the closing phase. The same calculations were 
undertaken to calculate the mean velocity for each of the phases across each of the 
blocks for the standardised chewing movements. 
The amplitude of the chewing movement, which is the distance in millimetres moved 
from the postural position to the point where the participant changed the direction of 
the movement, was also calculated for each cycle for each phase within a block of free 
or standardised chewing movements for each participant. The mean amplitude was 
calculated for each participant for each of the blocks of movements the same as for 
velocity. 
The mean velocity outgoing and closing phases were analysed using a mixed model 
Analysis of Variance (ANOVA) where block (Baseline, Block 1, Block 2 and Block 3) 
was the within subject factor and group (experimental pain and control) was the 
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between subject factor. The data was analysed for main effects of block and for 
interaction between block and group. 
The mean amplitude of the chewing movements was also analysed using a mixed 
model ANOVA to explore the main effects of block of the combined groups and an 
interaction of block and group membership of the participants. The analyses were 
undertaken separately for each of the phases within the free chewing movement and 
the standardised chewing movement. 
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Flowchart of Experimental Procedure 
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 Figure 2.5: Schematic of the experimental procedure showing positioning of each of the Blocks of recording EMG and jaw 
movement in relation to time and hypertonic saline infusion for the experimental pain group.  RDC/TMD: Research Diagnostic 
Criteria for TMD; PCS: Pain Catastrophizing Scale; VAS Visual Analogue Scale; DASS Depression, Anxiety and Stress Scale. 
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CHAPTER 3 
 
RESULTS 
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3.1 Participants 
Twenty healthy adults between the ages of 20 and 39 years of age participated in the 
study. None of the participants reported pain in the face or any other part of their body 
at the time of the experimental procedure. Ten participants were assigned to the 
experimental pain group and 10 to the control (no experimental pain) group. The 
experimental pain group consisted of 7 females and 3 males ranging in age from 24 
to 38 years. The control group consisted of 5 females and 5 males ranging in age from 
20 to 39 years. There was no significant difference (p = 0.52) between the 
experimental pain (mean 28.00, SD 6.16) and control (mean 29.5, SD 3.72) groups in 
age. 
A comparison of the self-report questions from the RDC/TMD history questionnaire 
indicated that the 2 groups were similar in the number of participants reporting oral 
parafunctions. One participant from each group reported having a previous experience 
of their jaw locking whilst 4 experimental pain and 2 control participants reported 
clicking or popping noises in one of their jaw joints. Nocturnal jaw clenching or grinding 
was reported by 2 participants from the experimental pain group and 4 participants 
from the control group. Stiffness in the movement of the jaw in the morning and 
daytime clenching and grinding were each reported by 1 participant in the 
experimental pain group and 1 participant in the control group. Problems with 
headache or migraine within the last 6 months were reported by 2 participants in the 
control group and 1 participant in the experimental pain group. 
The clinical examination component of the RDC/TMD indicated that the experimental 
pain and control group participants were not significantly different (Table 3.1) on 
measurements of maximum excursion of the jaw.  
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Table 3.1 Means and standard deviation (SD) for the two groups for each of the 
measured maximum jaw excursions derived from the RDC/TMD examination and the 
significance level of the difference between the experimental pain and control groups 
on each measure. 
 Mean (SD)  
Maximum jaw excursion 
Experimental 
Pain 
Control 
P value 
Opening (mm) 52.50 (6.20) 51.00 (8.31) 0.65 
Right lateral (mm) 11.20 (2.44) 10.10 (1.52) 0.24 
Left lateral (mm)  9.50 (2.72)  9.50 (1.96) 1.00 
Protrusion (mm)  9.40 (2.50)  8.10 (2.42) 0.26 
Significance = P< 0.05 
 
3.2 Questionnaires 
3.2.1 PCS  
The PCS was completed by all participants and each was scored to indicate the Total 
score out of a possible maximum score of 52, the quartile into which the Total score 
would be placed and a subset scores for those questions relating to Rumination, 
Magnification and Helplessness. The individual scores are shown in Table 3.2 for the 
experimental pain participants and in Table 3.3 for the control participants. 
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Table 3.2 Individual Pain Catastrophising Scores for the experimental pain group 
participants showing their Total score, their quartile of the Total score, their 
Rumination score, their Magnification score and their Helplessness score. Means 
and standard deviations (SD) of the group for each of the scores is also shown. 
Participant Total Quartile Rumination Magnification Helplessness 
1 19 2 9 3 7 
2 10 1 4 3 3 
4 5 1 3 2 0 
5 14 1 7 3 4 
6 9 1 6 0 3 
9 16 2 4 5 7 
13 7 1 2 0 5 
15 31 4 12 5 14 
19 18 2 11 1 6 
20 23 3 12 1 10 
Mean (SD) 15.2 (8.0)  7.0 (3.8) 2.3 (1.8) 5.9 (4.0) 
 
 
Analyses of the data indicated that there was no significant difference between the 
groups in the Total score (p = 0.12) and the subsets of Magnification (p = 0.07) and 
Helplessness (p = 0.09). A significant difference (p = 0.03) was found between the 
groups for the subset of Rumination with the experimental pain group having the 
higher mean value. 
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Table 3.3 Individual Pain Catastrophising Scores for the control group participants 
showing their Total score, their quartile of the Total score, their Rumination score, 
their Magnification score and their Helplessness score. Means and standard 
deviations (SD) of the group for each of the scores is also shown. 
Participant Total Quartile Rumination Magnification Helplessness 
3 0 1 0 0 0 
7 17 2 6 4 7 
8 0 1 0 0 0 
10 3 1 1 2 0 
11 25 3 10 7 8 
12 3 1 1 1 1 
14 0 1 0 0 0 
16 21 3 8 6 7 
17 14 2 5 4 5 
18 13 2 6 3 4 
Mean (SD) 9.6 (9.5)  3.7 (3.7) 2.7 (2.5) 3.2 (3.4) 
 
3.2.2 The Depression, Anxiety and Stress Scales (DASS) 
The scores for the depression, anxiety and stress scales for each of the participants 
were calculated from the relevant questions within the questionnaire with each scale 
having a maximum score of 28. Each of the participant’s scores is shown in Table 
3.4 for the experimental pain group and Table 3.5 for the control group. The scores 
for all participants were within the first quartile, that is, between 0 and 7. An 
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inspection of the group means and standard deviations (SD) shows that each 
group’s scores were similarly distributed on each of the scales. 
Statistical analyses of differences between the experimental pain and control groups 
for each of the domains found no significant difference for depression (p = 0.85), 
anxiety (p = 0.63) and stress (p = 0.25). 
Table 3.4 Individual and group mean (SD) scores for the depression, anxiety and 
stress scales of the DASS for the experimental pain group. 
Participant Depression Anxiety Stress 
1 3 5 4 
2 0 0 0 
4 0 0 0 
5 3 1 0 
6 2 5 4 
9 1 2 0 
13 0 1 1 
15 2 3 1 
19 0 0 0 
20 0 0 0 
Group Mean (SD) 1.1 (1.3) 1.7 (2.0) 1.0 (1.6) 
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Table 3.5 Individual and group mean (SD) scores for the depression, anxiety and 
stress scales of the DASS for the control group. 
Participant Depression Anxiety Stress 
3 0 0 0 
7 0 0 0 
8 2 4 2 
10 0 0 0 
11 3 4 3 
12 1 2 0 
14 1 0 0 
16 2 3 3 
17 0 0 0 
18 0 0 0 
Group Mean (SD) 0.9 (1.1) 1.3 (1.8) 0.8 (1.3) 
 
3.2.3 Pain Intensity Visual Analogue Scale (VAS) 
The intensity of the pain during the infusion of hypertonic saline into the right masseter 
muscle was measured on a 10 cm VAS after each trial of free chewing or standardized 
chewing. The mean and standard deviation (SD) of the pain intensity VAS scores after 
each of the three repeated trials of free chewing and of standardized chewing 
movements for each of the participants in the experimental pain group are shown in 
Table (3.6). A paired Student’s t-test found a significant difference (p = 0.01) between 
the free chewing and standardized chewing pain intensity scores. For 8 out of the 10 
participants, the free chewing movement was scored higher pain intensity than after 
the standardized chewing movement. 
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Table 3.6 Mean and standard deviations (SD) for pain intensity for each of the 
experimental pain group participants for the free and standardized chewing 
movements during infusion of hypertonic saline. 
 
 
 
 
 
 
 
 
Scores for the intensity of the muscle pain were also taken every minute during a 
washout period after the infusion of hypertonic saline had ceased. All participants in 
the experimental pain group provided pain intensity scores for at least 13 minutes’ post 
infusion at which time all scores were zero. Figure (3.1) indicates the decline in pain 
intensity perception across the wash out period. 
 
 Mean (SD) VAS Scores 
Participant Free Chew Standardised Chew 
1 5.67 (0.58) 5.67 (0.58) 
2 5.17 (0.29) 4.17 (0.76) 
4 5.33 (0.58) 4.17 (0.29) 
5 6.83 (0.29) 5.33 (0.58) 
6 6.67 (1.15) 5.50 (0.50) 
9 5.67 (0.58) 5.00 (0.00) 
13 6.33 (0.58) 3.67 (0.58) 
15 5.83 (0.76) 5.17 (0.76) 
19 3.83 (0.29) 4.67 (0.29) 
20 5.67 (3.21) 4.00 (1.00) 
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Figure 3.1. Mean VAS pain intensity scores for all of the ten experimental pain group 
participants across the washout period that was at least 13 minutes for all participants. 
3.2.4 Hypertonic Saline Infusion 
The infusion of hypertonic saline was commenced with a bolus to ramp up the level of 
pain to a moderate level, that is, 4 – 6 on the pain intensity VAS. After which the 
infusion pump was set to maintain a moderate perception of pain.  
Five of the 10 participants in the experimental pain group required a 0.1ml hypertonic 
saline bolus to obtain a moderate intensity of pain in the right masseter whilst the other 
5 participants required a 0.2ml bolus. In 3 of the 10 participants, the rate of infusion 
was changed, either increased or decreased during the 10-minute infusion block 
(Block1). The change in rate of infusion is shown in Table 3.7 in the first 3 participants 
which also displays the total infusion of hypertonic saline over the entire 10-minute 
period. 
Table 3.7. Infusion of hypertonic saline during Block 1 for each participant in the 
experimental pain group. 
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Participant Bolus ml 
Infusion 
rate ml/hr 
Total volume 
of hypertonic 
saline 
infused(ml) 
1 0.2 6-11  1.4 
2 0.2 8-12  1.8 
4 0.1 4-6  0.9 
5 0.1 2.5  0.3 
6 0.1 2 0.5 
9 0.2 2.5 0.5 
13 0.1 2.5  0.5 
15 0.2 2 0.5 
19 0.1 6 1.2 
20 0.2 4 1 
 
3.3 Jaw Movement 
All participants undertook two types of chewing movements, free chewing and 
standardized chewing, that was repeated three times each. Each set of chewing trials 
(that is, 6 trials) was undertaken 4 times, that is, 4 Blocks. The experimental pain group 
blocks consisted of a baseline Block (Baseline), a Block during the infusion of 
experimental pain (Block 1), a Block after the experimental pain had ceased with no 
less than a 10 minute interval (Block 2), and a Block after a further 5 minutes rest 
(Block 3). All of the 10 experimental pain participants completed all 4 Blocks of 
chewing trials. 
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For the control group the sequence was the same with the exclusion of the 
experimental pain experience (sham pain block; Block 1). Only 7 of the 10 participants 
in the control group completed all 4 blocks with 3 participants not completing a block 
of chewing trials during the second block (Block 1). 
3.3.1 Free Chewing 
During the free chewing trials of each Block, the participants chewed a pellet of gum 
for approximately 20 seconds at their own chewing rate.  
3.3.1.1 Velocity 
Velocity (mm/sec) was calculated by dividing the distance the jaw moved within the 
chewing movement by the time taken to move the jaw. Each chewing movement was 
divided into an opening or opening phase which was taken from the teeth together to 
the maximum gape of the mouth and a closing or closing phase when the jaw returned 
to the teeth together position. 
3.3.1.1.1 Velocity Opening phase 
Mean velocity for each participant for the opening phase of each Block and mean and 
standard deviations (SD) for each group is shown in Table 3.8. Statistical analyses of 
the opening phase did not find a significant effect of Block (p = 0.06) on velocity and 
no significant interaction (p = 0.26) between the experimental pain and control groups 
and the 4 Blocks. Inspection of the means and standard deviations indicates similar 
mean velocity between the groups although there is greater variability in the velocity 
of the movement for the experimental pain group compared to the control group. 
Table 3.8 Mean velocity (mm/sec) for the opening phase of the free chew movement 
for each participant in the experimental pain (Pain) and the control group. 
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Participat Group Baseline Block 1 Block 2 Block 3 
3 Control 29.07 30.78 44.20 43.42 
7 Control 50.68 51.33 49.89 56.76 
8 Control 32.54 38.38 43.83 45.96 
10 Control 33.92 37.52 46.73 47.88 
11 Control 30.79 40.23 47.63 43.10 
12 Control 23.80 37.40 35.24 31.72 
14 Control 31.18 30.94 39.10 46.67 
16 Control 30.31  40.73 37.28 
17 Control 23.23  27.93 36.29 
18 Control 25.64  29.14 33.71 
1 Pain 31.40 38.48 44.44 47.33 
2 Pain 80.13 100.41 44.29 50.43 
4 Pain 43.58 54.55 56.46 56.99 
5 Pain 15.67 17.59 23.94 25.87 
6 Pain 38.21 48.25 42.78 45.04 
9 Pain 25.63 35.32 30.92 36.01 
13 Pain 25.55 23.89 27.00 28.81 
15 Pain 22.33 26.10 26.43 33.14 
19 Pain 18.22 20.75 21.43 22.71 
20 Pain 33.78 38.68 49.53 46.24 
Control Mean (SD) 31.1 (7.8) 38.1 (6.9) 40.4 (7.6) 42.3 (7.6) 
Pain Mean (SD) 33.5 (18.6) 40.4 (24.2) 36.7 (12.2) 39.3 (11.4) 
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An inspection of the pairwise comparisons with Bonferroni corrections (Table 3.9) for 
all of the participants data together across all of the 4 Blocks indicated a significant 
difference in velocity between Baseline and Block 1 (p = 0.01), and Baseline and Block 
3 (p = 0.02). 
 
Table 3.9 Significance values (p values) for the difference in velocity between the 4 
Blocks during the opening phase of the free chewing movement for the combined data 
from the experimental pain and control groups. 
 Block 1 Block 2 Block 3 
Baseline 0.01 0.19 0.02 
Block 1  1.00 1.00 
Block 2   0.34 
Significance = P< 0.05 
 
3.3.1.1.2 Velocity Closing phase 
Mean velocity for the closing phase for each participant and group means and 
standard deviations (SD) for each of the Blocks has been displayed in Table 3.10. 
Analyses of the closing phase indicated a significant effect of Block (p = 0.00) although 
the interaction between the two groups and 4 Blocks were not significant (p = 0.35). 
Similar to the opening phase, the mean velocity is similar between the groups whilst 
the variability appears higher in the experimental pain group compared to the control 
group. 
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Table 3.10 Mean velocity (mm/sec) for the closing phase of the free chew movement 
for each participant in the experimental pain (Pain) and the control group. 
Participant Group Baseline Block 1 Block 2 Block 3 
3 Control 33.28 33.80 43.91 42.20 
7 Control 36.51 42.21 49.29 53.90 
8 Control 30.96 38.33 43.06 45.88 
10 Control 31.80 40.09 42.39 45.80 
11 Control 31.25 45.65 46.74 48.71 
12 Control 29.65 31.64 41.51 37.95 
14 Control 31.01 29.17 38.65 43.70 
16 Control 26.36  39.71 38.23 
17 Control 17.77  21.59 31.61 
18 Control 36.40  48.73 56.12 
1 Pain 29.13 39.06 42.32 45.25 
2 Pain 49.67 65.46 62.30 66.14 
4 Pain 35.12 44.84 49.13 50.08 
5 Pain 21.07 21.92 32.42 37.09 
6 Pain 31.68 47.98 42.11 45.54 
9 Pain 24.02 36.08 34.93 42.09 
13 Pain 25.40 22.77 31.40 32.94 
15 Pain 23.76 25.45 25.71 28.34 
19 Pain 18.91 24.32 22.29 26.19 
20 Pain 41.90 48.75 58.08 56.66 
Control Mean (SD) 30.5 (5.4) 37.3(6) 41.6 (7.9) 44.4 (7.4) 
Pain Mean (SD) 30.1 (9.8) 37.7 (14.4) 40.1 (13.3) 43.0 (12.6) 
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A further analysis of all of the participant’s data combined, using paired comparisons 
with Bonferroni corrections to determine differences between Blocks, showed that 
each Block was significantly different in velocity to each other. The significance values 
are shown in Table 3.11. The group means shown in Table 3.9 indicate that the overall 
mean velocity increased with the each additional Block of trials, that is, Baseline was 
the lowest velocity and Block 3 was the highest velocity. 
Table 3.11 Significance values (p values) for the difference in velocity between the 4 
Blocks during the closing phase of the free chewing movement for the combined data 
from the experimental pain and control groups. 
 Block 1 Block 2 Block 3 
Baseline 0.01 0.00 0.00 
Block 1  0.02 0.00 
Block 2   0.02 
Significance = P< 0.05 
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3.3.1.2 Amplitude 
The distance in millimetres (amplitude) that the jaw travelled during each free chewing 
movement was divided for analyses into the outgoing amplitude and the return 
amplitude of the movement as previously described. 
 
3.3.1.2.1 Amplitude Opening phase 
The mean amplitude of each Block of free chewing trials for each participant is 
shown in Table 3.12 with group means and standard deviations (SD). 
Analyses of the amplitudes found no significant effect (p = 0.18) of Block on the 
amplitude of the chewing movement and no significant interaction (p = 0.38) between 
the experimental pain and control groups and the 4 Blocks. 
Although not significantly different, mean amplitudes were shown to be higher for all 
blocks for the experimental pain group compared to the control group. Variability 
(SD) of the amplitude of the free chewing movement appears to be greater for the 
experimental pain group across all Blocks. 
 
 
 
 
Table 3.12 Mean amplitude (mm) for the opening phase of the free chew movement 
for each participant in the experimental pain (Pain) and the control group. 
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Participant Group Baseline Block 1 Block 2 Block 3 
3 Control 17.02 15.23 17.26 18.01 
7 Control 16.51 16.62 16.16 17.30 
8 Control 13.84 16.41 16.89 17.14 
10 Control 16.53 16.89 18.56 19.14 
11 Control 12.19 15.06 16.07 16.28 
12 Control 8.99 11.65 13.23 12.64 
14 Control 13.46 12.04 14.52 16.43 
16 Control 13.71  16.65 15.07 
17 Control 11.32  13.85 15.22 
18 Control 10.80  13.15 13.45 
1 Pain 16.83 17.62 19.02 19.12 
2 Pain 30.47 34.18 20.08 21.28 
4 Pain 16.49 18.86 19.85 20.31 
5 Pain 9.73 10.12 11.89 10.90 
6 Pain 15.76 15.26 15.69 15.04 
9 Pain 10.86 14.28 14.46 16.85 
13 Pain 16.58 14.35 15.77 15.82 
15 Pain 11.44 11.82 14.13 14.70 
19 Pain 11.58 11.43 10.51 11.74 
20 Pain 15.40 16.11 18.52 17.27 
Control Mean (SD) 13.4 (2.7) 14.8 (2.2) 15.6 (1.9) 16.1 (2.0) 
Pain Mean (SD) 15.5 (5.9) 16.4 (6.8) 16.0 (3.3) 16.3 (3.4) 
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An inspection of the pairwise comparisons with Bonferroni corrections (Table 3.13) of 
the combined amplitude of both the experimental and control groups found no 
significant differences between any of the 4 Blocks. 
Table 3.13 Significance values (p values) for the difference in amplitude between the 
4 Blocks during the opening phase of the free chewing movement for the combined 
data from the experimental pain and control groups. 
 Block 1 Block 2 Block 3 
Baseline 0.57 0.97 0.31 
Block 1  1.00 1.00 
Block 2   0.48 
Significance = P< 0.05 
3.3.1.2.2 Amplitude Closing phase 
Table 3.14 shows the mean amplitude for each of the participants across the 4 Blocks 
for the closing phase of the free chewing movement. Statistical analyses of the 
amplitude for the closing phase between the 4 Blocks did not show a significant effect 
(p = 0.18). Similarly, no interaction between the 4 Blocks and the 2 groups was found 
to be significant (p = 0.35). 
As with the amplitudes for the opening phase of the chewing movement, the mean 
amplitude for each Block was greater for the experimental pain group compared to the 
control group. Also similar was the greater variability (SD) in amplitude for the 
experimental pain group across all 4 Blocks. 
 Table 3.14 Mean amplitude (mm) for the closing phase of the free chew movement 
for each participant in the experimental pain (Pain) and the control group. 
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Participant Group Baseline Block 1 Block 2 Block 3 
3 Control 17.03 15.22 17.26 18.00 
7 Control 16.49 16.62 16.15 17.32 
8 Control 13.84 16.41 16.89 17.22 
10 Control 16.52 16.88 18.52 19.14 
11 Control 12.12 15.06 16.18 16.40 
12 Control 8.98 11.64 13.23 12.63 
14 Control 13.50 12.04 14.52 16.48 
16 Control 13.84  16.47 15.09 
17 Control 11.54  14.12 15.26 
18 Control 10.88  13.17 13.45 
1 Pain 16.83 17.60 18.93 19.15 
2 Pain 30.49 34.03 20.10 21.28 
4 Pain 16.50 18.88 19.90 20.33 
5 Pain 9.93 10.12 11.89 10.93 
6 Pain 15.75 15.41 15.77 15.10 
9 Pain 10.86 14.27 14.54 16.79 
13 Pain 16.64 14.39 15.84 15.89 
15 Pain 11.87 11.82 14.24 14.74 
19 Pain 11.60 11.57 10.53 11.74 
20 Pain 15.41 16.28 18.43 17.23 
Control Mean (SD) 13.5 (2.7) 14.8 (2.2) 15.7 (1.8) 16.1 (2.0) 
Pain Mean (SD) 15.6 (5.9) 16.4 (6.8) 16.0 (3.3) 16.3 (3.4) 
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Similar to analyses of the amplitudes of the opening phase of the free chewing 
movement, pair wise comparisons with Bonferroni corrections (Table 3.15) did not 
show any significant differences between the 4 Blocks when the 2 group’s data were 
combined. 
Table 3.15 Significance values (p values) for the difference in amplitude between the 
4 Blocks during the closing phase of the free chewing movement for the combined 
data from the experimental pain and control groups. 
 Block 1 Block 2 Block 3 
Baseline 0.61 0.98 0.31 
Block 1  1.00 1.00 
Block 2   0.42 
Significance = P< 0.05 
3.3.2 Standardized Chewing 
3.3.2.1 Velocity 
As with the free chewing movement, velocity was divided into the outgoing and 
closing phase of each of the standardised chewing movements.  
3.3.2.1.1 Velocity Opening phase 
Mean velocity for each of the 4 Blocks for each of the participants in the control and 
experimental pain groups during the opening phase is shown in Table (3.16). The 
statistical analysis of the velocity found an almost significant effect of Block (p = 0.05) 
but not a significant interaction (p = 0.32) between the 4 Blocks and the 2 groups, 
experimental and control. 
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Table 3.16 Mean velocity (mm/sec) for the opening phase of the standardised chewing 
movement for each participant in the experimental pain (Pain) and the control group.  
Participant Group Baseline Block 1 Block 2 Block 3 
3 Control 38.82 42.64 45.63 46.93 
7 Control 44.21 42.92 37.43 40.18 
8 Control 34.82 38.98 43.09 40.47 
10 Control 33.10 34.58 39.17 47.37 
11 Control 26.23 33.28 37.88 40.29 
12 Control 16.63 26.09 26.76 27.27 
14 Control 30.43 32.77 33.93 50.37 
16 Control 32.75  33.32 28.60 
17 Control 31.84  38.19 34.00 
18 Control 27.33  27.28 25.22 
1 Pain 33.14 35.24 38.79 47.55 
2 Pain 76.31 52.87 40.88 42.70 
4 Pain 38.05 40.67 49.67 47.59 
5 Pain 14.05 23.23 25.09 25.50 
6 Pain 38.97 37.97 37.03 41.38 
9 Pain 35.55 30.66 37.07 41.43 
13 Pain 28.57 31.67 31.07 31.23 
15 Pain 21.95 13.68 24.54 32.66 
19 Pain 20.63 22.27 23.84 24.33 
20 Pain 36.15 35.64 32.39 38.53 
Control Mean (SD)  31.6 (7.4) 35.9 (6.0) 36.3 (6.1) 38.1 (8.9) 
Pain Mean (SD)  34.3 (17.0) 32.4 (10.9) 34.0 (8.3) 37.3 (8.4) 
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Pair wise comparisons with Bonferroni corrections of the velocity of the combined 
experimental and pain groups (Table 3.17) did not find any significant differences 
between the Blocks. The differences between Block 3 and Block 1, and Block 3 and 
Block 2 did approach significance. 
Table 3.17 Significance values (p values) for the difference in velocity between the 4 
Blocks during the opening phase of the standardised chewing movement for the 
combined data from the experimental pain and control groups. 
 Block 1 Block 2 Block 3 
Baseline 1.00 1.00 0.24 
Block 1  1.00 0.07 
Block 2   0.05 
Significance = P< 0.05 
3.3.2.1.2 Velocity Closing phase 
The mean velocity of the closing phase of the standardised chewing movement for 
each of the participants across each of the 4 Blocks is shown in Table (3.18).  
Analyses of the velocity data indicated significant effect of Block (p = 0.00) across 
the participants but did not show a significant interaction (p = 0.73) between the 4 
Blocks and the 2 groups, experimental pain and control. 
Table 3.18 Mean velocity (mm/sec) for the closing phase of the standardised 
chewing movement for each participant in the experimental pain (Pain) and the 
control group. 
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Participant Group Baseline Block 1 Block 2 Block 3 
3 Control 39.93 44.90 38.88 39.17 
7 Control 34.72 35.38 42.88 38.57 
8 Control 35.32 38.00 39.08 40.16 
10 Control 33.41 38.33 35.85 35.79 
11 Control 26.09 30.30 35.37 36.18 
12 Control 20.83 30.04 33.13 35.72 
14 Control 30.96 33.10 35.94 49.10 
16 Control 30.58  31.70 30.27 
17 Control 30.21  31.41 32.91 
18 Control 37.75  45.23 41.66 
1 Pain 33.61 39.18 34.96 35.72 
2 Pain 49.90 47.88 53.28 54.69 
4 Pain 34.35 38.18 43.88 58.28 
5 Pain 17.51 29.63 33.43 31.34 
6 Pain 33.45 34.95 41.35 33.74 
9 Pain 35.77 33.91 40.42 45.27 
13 Pain 29.30 37.06 33.46 38.42 
15 Pain 17.03 11.43 21.71 27.68 
19 Pain 23.63 28.48 28.60 31.20 
20 Pain 44.15 39.18 50.12 49.06 
Control Mean (SD)  32 (5.6) 35.7 (5.2) 37.0 (4.6) 38.0 (5.2) 
Pain Mean (SD)  31.9 (10.6) 34.0 (9.6) 38.1 (9.6) 40.5 (10.7) 
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Further analyses of the velocity data using the combined velocity of the experimental 
pain and control groups for the closing phase of the standardised chewing 
movement indicated a significant difference (Table 3.19) between Baseline and 
Block 2, and Baseline and Block 3. 
Table 3.19 Significance values (p values) for the difference in velocity between the 4 
Blocks during the closing phase of the standardised chewing movement for the 
combined data from the experimental pain and control groups. 
 Block 1 Block 2 Block 3 
Baseline 0.11 0.00 0.00 
Block 1  0.20 0.09 
Block 2   0.83 
Significance = P< 0.05 
 
3.3.2.2 Amplitude 
The amplitude in millimetres of the standardised chewing movement was also 
analysed in two parts, the opening phase and the closing phase. 
3.3.2.2.1 Amplitude Opening phase 
Each participant’s mean amplitude for the opening phase of the standardised 
chewing movement across the 4 Blocks is shown in Table (3.20). 
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Table 3.20 Mean amplitude (mm) for the opening phase of the standardised chewing 
movement for each participant in the experimental pain (Pain) and the control group. 
Participant Group Baseline Block 1 Block 2 Block 3 
3 Control 16.74 18.64 17.50 18.69 
7 Control 15.83 15.71 16.62 16.26 
8 Control 14.78 16.88 17.41 17.45 
10 Control 13.14 14.22 15.64 17.68 
11 Control 11.00 13.02 14.84 15.47 
12 Control 7.77 11.83 12.70 13.12 
14 Control 13.01 13.01 12.58 18.24 
16 Control 12.87  13.26 11.92 
17 Control 13.46  14.91 14.33 
18 Control 13.07  14.20 12.93 
1 Pain 13.15 14.41 15.53 17.64 
2 Pain 26.79 20.77 19.42 19.87 
4 Pain 14.66 16.80 18.89 20.17 
5 Pain 6.50 11.46 12.44 12.20 
6 Pain 14.62 15.03 16.72 16.08 
9 Pain 15.71 13.68 16.77 18.74 
13 Pain 14.99 15.52 14.53 15.07 
15 Pain 8.27 5.29 9.87 13.30 
19 Pain 10.19 10.97 10.88 11.07 
20 Pain 14.52 16.02 16.38 17.77 
Control Mean (SD)  13. (2.5) 14.8 (2.4) 15.0 (1.8) 15.6 (2.4) 
Pain Mean (SD)  13.9 (5.5) 14.0 (4.1) 15.1 (3.2) 16.2 (3.2) 
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Statistical analyses of the amplitude of the opening phase indicated that there was a 
significant effect of Block (p = 0.00) although there was no significant interaction 
between the 2 groups and the 4 Blocks (p = 0.55). 
Analysis of the difference between the 4 Blocks for the combined data from the 
experimental pain and control group (Table 3.21) demonstrated significant differences 
between Baseline and Block 3, Block 1 and Block 3, and Block 2 and Block 3. 
Table 3.21 Significance values (p values) for the difference in amplitude between the 
4 Blocks during the opening phase of the standardised chewing movement for the 
combined data from the experimental pain and control groups. 
 Block 1 Block 2 Block 3 
Baseline 1.00 0.22 0.01 
Block 1  0.24 0.02 
Block 2   0.04 
Significance = P< 0.05 
 
3.3.2.2.2 Amplitude Closing phase 
Each participant’s mean amplitude for the closing phase of the standardised chewing 
movement is displayed in Table (3.22). 
Analyses of the closing phase found a significant difference between the 4 Blocks 
across all of the data (p = 0.00) although there was no significant interaction between 
the 4 Blocks and the 2 groups (p = 0.56). 
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Table 3.22 Mean amplitude (mm) for the closing phase of the standardised chewing 
movement for each participant in the experimental pain (Pain) and the control group. 
  
Participant Group Baseline Block 1 Block 2 Block 3 
3 Control 16.74 18.64 17.55 18.69 
7 Control 15.84 15.78 16.63 16.30 
8 Control 14.76 16.88 17.42 17.44 
10 Control 13.13 14.24 15.70 17.68 
11 Control 10.99 13.06 14.95 15.50 
12 Control 7.75 11.80 12.70 13.12 
14 Control 13.04 13.04 12.61 18.26 
16 Control 13.04  13.30 12.00 
17 Control 13.53  14.92 14.41 
18 Control 13.09  14.19 12.93 
1 Pain 13.14 14.42 15.53 17.65 
2 Pain 26.80 20.87 19.41 19.88 
4 Pain 14.65 16.83 19.01 20.75 
5 Pain 6.51 11.46 12.43 12.20 
6 Pain 14.75 15.17 16.90 16.24 
9 Pain 15.68 13.75 17.02 18.86 
13 Pain 15.18 15.45 14.54 14.87 
15 Pain 8.40 5.37 10.04 13.43 
19 Pain 10.16 10.99 10.92 11.09 
20 Pain 14.45 16.04 16.61 18.02 
Control Mean (SD)  13.2 (2.5) 14.8 (2.4) 15.00 (1.8) 15.6 (2.4) 
Pain Mean (SD)  14.0 (5.5) 14.0(4.1)  15.2 (3.2) 16.3 (3.3) 
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Paired comparisons with Bonferroni corrections identified significant differences 
between the Blocks (Table 3.23) when the data of all the participants were 
combined. Block 3 was significantly different to Baseline and Block 1. The difference 
between Block 3 and Block 2 approached significance. 
Table 3.23 Significance values (p values) for the difference in amplitude between the 
4 Blocks during the closing phase of the standardised chewing movement for the 
combined data from the experimental pain and control groups. 
 Block 1 Block 2 Block 3 
Baseline 1.00 0.20 0.01 
Block 1  0.21 0.02 
Block 2   0.05 
Significance = P< 0.05 
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DISCUSSION 
Overview of study and main findings 
About 10% of patients with TMD progress to chronic TMD pain and disability. It is 
unclear why some patients progress to chronic pain while others do not. Various 
possible reasons could be genetic and deficiencies in central pain modulatory 
systems have been implicated. Another factor that might contribute to the transition 
from acute to chronic TMD pain is that the jaw motor system may develop a new 
pattern of jaw movement and muscle activity in some individuals who experience an 
acute episode of jaw muscle pain and this new pattern may actually generate more 
pain. It is possible that the neuroplastic changes that might be occurring in 
association with orofacial pain, possibly influenced by some psychological factors, 
might lead to changes in jaw motor activity that may possibly predispose an 
individual to a return of symptoms. The general hypothesis of this thesis therefore is 
that following a resolution of a brief episode of orofacial pain, there are significant 
changes in jaw motor activity that persist beyond the period of pain. 
The aims were: 
 
1.To determine whether a continuous infusion of hypertonic saline results in 
significant changes in jaw movement velocity and amplitude during chewing in 
comparison with control. 
2.To investigate whether a continuous infusion of hypertonic saline results in 
significant changes in jaw movement velocity and amplitude during chewing in 
 comparison with control that are apparent after the resolution of the pain 
following cessation of the infusion of hypertonic saline. 
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The first specific hypothesis is that a continuous infusion of hypertonic saline into the 
masseter muscle results in an experience of moderate pain in healthy individuals 
and this infusion lead to significant reductions in jaw movement amplitude and 
velocity of chewing in comparison with a control group. The second specific 
hypothesis is that continuous infusion of hypertonic saline results in significant 
changes in jaw movement velocity and amplitude during chewing in comparison with 
control that are apparent after the resolution of the pain following cessation of the 
infusion of hypertonic saline.  
The findings of the present study show that in comparison with a matched control 
group, there were no significant effects of pain on the kinematic features namely, 
amplitude or velocity of jaw movement during the opening and closing phases of 
both free and standardized chewing. The data showed that while there may be an 
increase in the amplitude and/or velocity of jaw movement during pain, these same 
effects occurred in the matched control group.  
The data further indicate that following a short period of moderate experimental pain, 
produced through injection of hypertonic saline into the masseter muscle in healthy 
individuals, does not lead to changes in jaw movement amplitude or velocity of free 
or standardized chewing that are due to the previous experience of pain. Increases 
in amplitude and/or velocity were observed in free or standardized chewing but these 
effects were noted in both the pain and control groups. Therefore, the changes 
cannot be attributed to the experimental pain period but reflect other factors relating 
to the experiment, such as motivational factors. All the findings do not support the 
hypothesis of post-pain changes in jaw movement amplitude and velocity and jaw 
muscle EMG activity in chewing and suggest that, at least following a brief acute 
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experimental pain stimulus, there are no persistent post-pain effects on chewing 
activity.  
Comparability between control and pain groups 
The participants in the experimental pain and control groups were well matched in 
terms of age, gender, reports of oral parafunctions, and maximum jaw excursions. 
They were also well matched in terms of their scores from the PCS and the 
Depression, Anxiety and Stress Scales. There was a significant difference for the 
one of the subset scores for Rumination which was higher in the control group. 
Pain intensity scores 
Injections of hypertonic saline into the masseter muscle resulted in pain intensity 
scores of ~4-6 cm on a 10 cm VAS line and these scores were comparable to 
previous studies that have injected hypertonic saline into the jaw muscles (Sae-Lee 
et al  2008a,b; Akhter et al. 2014; Svensson et al 1997; Svensson and Graven-
Nielsen 2001) and into the limb or trunk muscles (Hodges et al 2005). These scores 
are also comparable to scores reported in patients with TMD (Gustin et al 2011). 
There was a significant difference (p = 0.01) between the free chewing and 
standardized chewing pain intensity scores with the scores during standardized 
chewing being lower than those for the free chewing. One explanation could be that 
the standardized chewing sequence was always performed after the free chewing 
sequence and the lowered pain intensity might reflect a time-related effect. The 
habituation that is known to occur with continuous infusion of hypertonic saline may 
have played a role in this (Stohler et al 1996, Svensson et al 1988). Although the 
continuous infusion was monitored continuously throughout the infusion period, the 
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natural reduction in pain intensity that participants experience after a few minutes of 
hypertonic saline infusion (Stohler et al 1998) may not have been fully compensated 
for by the manual adjustments to the infusion rate.  
All participants in the experimental pain group were completely pain free after 10-12 
minutes of cessation of the infusion. This time is comparable to previous reports of 
the time taken for pain to decrease to zero after cessation of hypertonic saline 
infusion in both trigeminal and spinal systems (Svensson and Graven-Nielsen 2001; 
Sae-Lee et al 2008a, Akhter et al 2014). Therefore, subsequent recordings of jaw 
movements in the post-pain period were carried out in the absence of pain, and 
these recordings in the absence of pain provide an assessment of possible post-pain 
effects on jaw movement. 
Effects of pain on movement – control group vs. experimental pain group 
While many of the comparisons between blocks for the combined data from both 
groups demonstrated significant differences often between baseline and one or more 
of the blocks, there were no significant differences noted between the control and 
pain groups. These data indicate that pain was not having any effect on the jaw 
movement amplitudes or velocities during free or standardized chewing. Although 
there were significant effects of Block noted for some of the kinematic variables, 
there were no significant interactions between the 2 groups and the 4 Blocks for any 
of the kinematic variables. There was a suggestion, however, that the pain group 
may be demonstrating greater variability in some of these parameters than the 
control group.  
There have been many studies of the effects of experimental or clinical orofacial pain 
on jaw movement kinematics in command jaw movements (such as simple open-
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close jaw movements) or chewing jaw movements (for review, Murray and Peck 
2007; Svensson and Graven-Nielsen 2001). The findings of the present study of no 
effects of pain on jaw movement kinematics during chewing is consistent with the 
findings of some previous studies showing that experimental or clinical pain was not 
associated with reductions in the amplitude or velocity of jaw movements during 
chewing (Brandini et al 2011; Sae-Lee et al 2008; Svensson et al 1997; Stohler et 
al., 1988; Bhaskaracharya et al 2015). Furthermore, some of these earlier studies 
showed that experimental or clinical pain could be associated with increased jaw 
movement variability (Stohler et al 1988; Schwartz and Lund 1995) and in a recent 
study, slower velocity and greater variability of repetitive jaw movements has been 
observed in higher pain catastrophizing individuals in acute experimental pain 
(Akhter et al 2014). These earlier findings may be consistent with the suggestive 
data in the present study showing increased variability of some kinematic 
parameters during chewing in the presence of pain.  
However, this greater variability in the pain group in comparison with the control 
group appeared to be present in the baseline block as well as in subsequent blocks. 
This greater variability may reflect therefore the anticipation of or an anxiety about 
the pain by the individuals in the pain group. Everyone knew that they would receive 
an injection of hypertonic saline whereas the control group knew that they would not 
receive any such injection.  
Another reason, possibly in combination with the anticipation or anxiety issue 
mentioned above, could relate to an aspect of the Vicious Cycle Theory as described 
in the Introduction. One mechanism is thought to operate through the gamma–
motoneuron innervation of muscle spindles (Johansson and Sojka 1991). While 
aspects of this theory are unlikely to operate in its original form, nonetheless there is 
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evidence that local inflammatory mediators can activate muscle nociceptive afferents 
which can alter the activity of gamma-motoneurons and thereby decrease the fidelity 
of spindle afferent transmission (Capra et 2007). There may be a loss of 
proprioceptive acuity that may lead to a less efficient muscular coordination and a 
greater accumulation of metabolites and thereby more pain (reviewed in Murray and 
Peck 2007). The greater variability noted in the chewing trials during pain, and not in 
the control group, may be arising because of this impaired proprioceptive feedback 
from muscle spindle afferents arising because of the hypertonic saline infusion. 
Alternatively, or together, the greater variability may reflect the decreased excitability 
of the face motor cortex that is known to occur with noxious masseter or tongue 
muscle stimulation (Adachi et al  2008; Nash et al  2010). The motor cortex is known 
to play a role in the fine control and modulation of chewing and this may be impaired 
with noxious masseter muscle stimulation. 
Findings in relation to previous models of the pain-motor interaction 
One of the main models explaining the association between pain and motor activity 
has been the Pain Adaptation Model. This model proposes that pain leads to 
reduced amplitude and velocity of movement so as to promote healing (Lund et al 
1991; Lund,2008; Murray and Peck, 2007) and the model has been shown to have 
some applicability in both spinal and trigeminal motor systems (Murray and Peck, 
2007;van Dieën et al., 2003). There are many previous studies both in the trigeminal 
and spinal motor systems that provide data sets that are consistent with this model 
(Svensson et al 2001; Lund et al 1991; Stohler, 1999; Svensson et al 1996; 
Svensson et al 1997; Svensson et al1998; Akhter et al  2014; Van Dieën et al., 
2003).  
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However, there are many other studies that provide data sets that are not consistent 
with the Pain Adaptation Model (van Dieën et al 2003; Murray and Peck 2007). One 
of the explanations as to why, in some studies, pain does not seem to result in a 
reduction in the amplitude and/or velocity of movement as proposed by the Pain 
Adaptation Model, could relate to the goal-directed nature of some of the tasks that 
were performed in these earlier studies. Thus, in some of these previous studies, 
individuals carried out a task requiring achievement of certain task parameters and it 
is possible that in some of these previous studies, this need to achieve certain task 
parameters was able to override or reduce the inhibitory effects of nociceptive 
activity on motor activity.  
In the present study, 2 chewing tasks were carried out. While the free chewing task 
was not goal-directed in that the participants were instructed to chew normally, the 
standardized chewing task had features of a goal-direct task in that participants were 
instructed to chew in time with a standardized timer. For the standardized chewing 
task, the motivation of the participants to follow a set timing for the chewing rate may 
well have overridden any inhibitory effect on motor activity due to the pain. The free 
chewing was not goal-directed in any way but no effect of pain was noted. This 
absence of an effect may reflect the nature of the participants in this study where the 
individuals who were willing to participate were high functioning with no 
demonstrable psychosocial issues that might influence their ability to tolerate the 
short period of pain. The mostly low PCS and DASS scores for both groups of 
individuals demonstrate the high functioning of these individuals. It is noteworthy in 
relation to the absence of a pain effect on both tasks that participants in pain can 
chew more quickly if necessary (Svensson and Graven-Nielsen  2001; Sae-Lee et 
al., 2008; Brandini et al., 2011). 
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It is proposed that the absence of a pain effect on the kinematic parameters as 
demonstrated in the present study is a reflection of the emerging notion (Murray and 
Peck, 2007; Hodges and Tucker 2011) that the association between pain and motor 
activity is not a hard-wired segmental or brainstem level response that has been 
suggested in previous models (i.e. Pain Adaptation Model, Vicious Cycle Theory) but 
is subject to major influences from higher centers. As has been previously pointed 
out (Brandini et al 2011; Svensson and Graven-Nielsen, 2001; Akhter et al., 2014) 
this ability of individuals to perform a motor task in the presence of pain is likely to be 
of significance where orofacial pain patients need to perform a demanding task, e.g., 
clearly articulated speech in demanding work situations. 
Possible post-pain effects 
We found no evidence of a pain-related change in amplitude or velocity of jaw 
movement up to 30 min after the brief pain episode. Neuroplastic changes are 
known to occur in sensorimotor cortical areas following peripheral manipulations of 
sensory inputs into and motor outputs from the brain (Sessle 2006). There is 
evidence that the face area of the primary motor cortex (that drives voluntary 
orofacial movements) is markedly affected by noxious orofacial stimulation (Adachi 
et al 2008; Nash et al 2010). These inhibitory effects appear to outlast the period of 
the noxious muscle stimulation (Adachi et al 2008; Nash et al 2010). Therefore, in 
this present experimental paradigm, the primary motor cortex would likely be 
inhibited by noxious masseter muscle stimulation. However, the absence of any 
apparent inhibitory influence from the pain on jaw motor activity during either free 
chewing or standardized chewing suggests that any changes in primary motor cortex 
activity that might persist after the pain has subsided, are insufficient to lead to a 
reduction in jaw motor activity during either free or standardized chewing.  
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Also, the motor tasks may be too coarse in demonstrating any persistent motor 
effect. A more refined motor task may be necessary in order to demonstrate and the 
same paradigm employing other tasks is an avenue for further investigation. 
The findings further indicate that possible persistent effects of pain are not the 
reason for the increased velocity and amplitude of chewing noted in a previous 
experimental pain study during hypertonic or isotonic infusion into the masseter 
muscle in comparison with control chewing (Sae-Lee et al 2008a). In this earlier 
experimental study asymptomatic participants chewed faster and exhibited larger 
amplitude gapes during both hypertonic and isotonic saline infusion into the 
masseter muscle in comparison with control chewing. One possibility that might 
explain the absence of significant differences between the hypertonic saline and 
isotonic saline infusion conditions in this earlier study, is that there may be persistent 
effects of a previous experience of pain (e.g. hypertonic saline infusion) on 
subsequent experimental trials (e.g. isotonic saline infusion). The present findings do 
not support such a conclusion. Rather they point to the possibility that the increases 
in amplitude and/or velocity of jaw movement during chewing and during and after 
hypertonic saline infusion, are due to practice effects or some effects related to the 
motivation to complete the experiment as quickly as possible. 
These findings also underscore the importance of a matched control group for these 
sorts of experimental pain studies. Without a matched control group undergoing 
exactly the same protocol but without pain, the conclusion may have been 
erroneously made that pain was indeed having an effect. 
 
 
91 
 
Limitations 
First, this is an exploratory study, where we used a single bolus injection of 
hypertonic saline as an acute experimentally induced pain stimulus. The 
demonstration of possible post-pain effects may require a greater volume to be 
injected over a longer time, which is still unclear. Second, psychological and 
emotional effects often accompany real life pain, and the experimental pain 
paradigm employed here may have limited direct relevance to unexpected acute 
pain including chronic pain as the experimental participants will not have the same 
psychological effects. These differences between experimental pain, acute pain and 
chronic pain might influence the expression of pain-related effects on movement. 
Third, the sample size was relatively small, limiting its power. Finally, this was an 
initial exploratory study to allow sample size estimation for future studies. The above 
limitations will need to be addressed in future research. 
 
Future studies 
The motor tasks performed in the present study may be too coarse to demonstrate 
any persistent motor effects. A more refined motor task may be necessary in order to 
demonstrate and the same paradigm employing other tasks is an avenue for further 
investigation. Although no kinematic effects were noted, there may be changes in 
jaw muscle activity occurring and these effects could be studied. 
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Conclusions 
The findings of the present study show that in comparison with a matched control 
group, there were no significant effects of pain on the amplitude or velocity of jaw 
movement during chewing. The data showed that while there may be an increase in 
the amplitude and/or velocity of jaw movement during pain, these same effects 
occurred in the matched control group. The data further indicate that following this 
short period of moderate experimental pain, there are no changes in jaw movement 
amplitude or velocity of chewing that are due to the previous experience of pain. The 
present findings therefore do not support the general hypothesis of this thesis that 
following a resolution of a brief episode of orofacial pain, there are significant 
changes in jaw motor activity that persist beyond the period of pain. 
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  Appendix 1 
                       SCREENING QUESTIONNAIRE 
       
ID:  __________       Gender : __________  
     
Please indicate whether you have used any of the following substances in the past 24 hours : 
      (circle one)  (if YES) 
CAFFEINE (e.g. tea/coffee)   YES / NO When ______   Qty __________ 
ALCOHOL     YES / NO When ______   Qty __________ 
         (circle one) 
   Have you ever been hospitalised?      YES / NO 
If YES, please specify:  
_______________________________________________________________________________
__ 
 
Are you receiving treatment for any medical condition?   YES / NO 
If YES, please specify: 
_______________________________________________________________________________
__ 
 
Are you taking any medications?     YES / NO 
If YES, please specify: 
_______________________________________________________________________________
__ 
 
Do you have excessive bleeding when you cut yourself?   YES / NO 
If YES, please, specify: 
_______________________________________________________________________________
__ 
 
   Have you ever received treatment for any of the following: 
      (circle one) (If YES – give details please) 
HEART PROBLEMS    YES / NO __________________________ 
RESPIRATORY PROBLEMS   YES / NO  __________________________ 
RHEUMATIC FEVER     YES / NO  __________________________  
DIABETES     YES / NO __________________________ 
BLOOD PRESSURE    YES / NO __________________________ 
COMMUNICABLE DISEASES   YES / NO __________________________ 
(e.g. Hepatitis) 
Are you experiencing any of the problems now? YES / NO__________________________ 
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Appendix 2 
 
CLINICAL RESEARCH DIAGOSTIC CRITERIA (RDC) EXAMINATION 
 
 
1. Do you have pain on the right side of your face,    None  0 
the left side or both.        Right 
 1 
            Left  2 
            Both  3 
 
 
2. Could you point to the areas where you feel pain?   Right   Left 
         None  0 None  0 
         Jaw Joint 1 Jaw Joint 1 
         Muscles 2 Muscles 2 
         Both  3 Both  3 
 
(Examiner feels area subject points to, if it is unclear whether it is joint or muscle.) 
 
 
3. Opening Pattern   Straight      0 
       Right Lateral Deviation (uncorrected)   1 
       Right Corrected (“S”) Deviation   2 
       Left Lateral Deviation (uncorrected)   3 
       Left Corrected (“S”) Deviation     4 
       Other       5 
       Type(specify) __________________________________ 
 
 
 
4. Vertical Range of Motion   Maxillary incisor used   (0) 1.1 
             (1) 2.1 
 
(a) Unassisted opening without pain ______ mm  
         MUSCLE PAIN            JOINT PAIN 
              None   Right   Left   Both      None   Right   Left   
Both 
(b) Maximum unassisted opening ______ mm  0        1        2       3       0        1        2        
3 
 
(c) Maximum assisted opening     ______ mm  0        1       2       3             0        1         2       
3 
 
(d) Vertical incisal overlap      ______ mm 
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5. Joint Sounds (palpation)      RIGHT  
 LEFT 
(a)  Opening    None        0         0 
      Click        1         1 
 Coarse Crepitus 5           5 
      Fine Crepitus       6            6 
 
Measurement of Opening Click   _____ mm 
 _____ mm 
 
 
(b)  Closing    None        0        0 
      Click        1         1 
 Coarse Crepitus 5            5 
      Fine Crepitus       6            6 
 
Measurement of Closing Click   _____ mm 
 _____ mm 
 
 
(c) Reciprocal click eliminated on protrusive opening 
 
     No      No 
    Yes     Yes 
        
 
6. Excursions     MUSCLE PAIN           JOINT PAIN 
          None   Right   Left   Both          None   Right   Left   
Both 
(a) Right Lateral Excursion     ______ mm       0         1        2       3     0        1        2        
3 
 
(b) Left Lateral Excursion       ______ mm       0         1        2       3               0        1         2       
3 
 
(c) Protrusion           ______ mm       0         1        2       3               0        1         2       
3 
 
           
(d) Midline Deviation         ______ mm  (0)   RIGHT         (1)    LEFT         (2)   NA 
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7. Joint Sounds on Excursions 
 
Right Sounds:           Coarse    
Fine 
        None        Click        Crepitus
 Crepitus  
    Excursion Right    0      1          5      3 
    Excursion Left     0      1          5      3 
    Protrusion     0      1          5      3 
 
 
Left Sounds:           Coarse    
Fine 
        None        Click        Crepitus
 Crepitus  
    Excursion Right    0      1          5      6 
    Excursion Left     0      1          5      6 
    Protrusion     0      1          5      6 
 
 
 
 
 
 
DIRECTIONS FOR ITEMS 8-10 
 
The examiner will be palpating (touching) different areas of your face, head and neck. 
We would like you to indicate if you do not feel pain of just feel pressure (0), or pain (1-3). 
Please rate how much pain you feel for each of the palpations according to the scale below. 
Circle the number that corresponds to the amount of pain you feel. We would like you to 
make a separate rating for both the right and left palpations. 
 
 
0 = No Pain/ Pressure Only 
1 = Mild Pain 
2 = Moderate Pain 
3 = Severe Pain 
 
 
PLEASE GIVE PATIENT RATING CARD 
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8. Extraoral muscle pain with palpation: 
          RIGHT    LEFT 
a. Temporalis (posterior)     0  1  2  3  0  1  2  3 
 “Back of temple” 
 
b. Temporalis (middle)     0  1  2  3  0  1  2  3 
 “Middle of temple” 
 
c. Temporalis (anterior)     0  1  2  3  0  1  2  3 
 “Front of temple” 
 
d. Masseter (superior)     0  1  2  3  0  1  2  3 
 “Cheek/under cheekbone” 
 
e. Masseter (middle)     0  1  2  3  0  1  2  3 
  “Cheek/side of face”   
 
f. Masseter (inferior)     0  1  2  3  0  1  2  3 
 “Cheek/jawline 
 
g. Posterior mandibular region    0  1  2  3  0  1  2  3 
 (Stylohyoid/posterior digastric region) 
 “Jaw/throat region” 
 
h. Submandibular region    0  1  2  3  0  1  2  3 
 (Medial pterygoid/Suprahyoid/anterior 
 digastric region) “Under chin” 
 
i.  Sternocleidomastoid (origin)    0  1  2  3  0  1  2  3 
 “Under ear” 
 
j.  Sternocleidomastoid (body)    0  1  2  3  0  1  2  3 
 “Side of neck” 
 
k. Trapezius (origin)     0  1  2  3  0  1  2  3 
 “Back of head” 
 
l.  Trapezius (body and insertion)   0  1  2  3  0  1  2  3 
 “Neck and shoulders 
9. Joint pain with palpation: 
a.  Lateral pole       0  1  2  3  0  1  2  3 
 “Outside” 
 
b. Posterior attachment     0  1  2  3  0  1  2  3 
 “Inside ear” 
10. Intraoral muscle pain with palpation: 
a. Lateral pterygoid area     0  1  2  3  0  1  2  3 
 “Behind upper molars” 
 
b. Tendon of temporalis     0  1  2  3  0  1  2  3 
 “Tendon” 
 
c. Tongue      0  1  2  3  0  1  2  3 
 “Tongue” 
 
11. Is pain on same side as reported in question 2?  Yes   No 
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Appendix 3 
 
RDC/TMD HISTORY QUESTIONNAIRE     
1. Please read each question and respond accordingly. For each of the questions below 
circle only one response. 
 
1. Would you say your health in general is:      
Excellent  Very good  Good   Fair   Poor  
  
2. Would you say your oral health in general is:    
Excellent  Very good  Good   Fair   Poor 
         
3. Have you had pain in the face, jaw, temple, in front of the ear or in the ear in the past 
month?          No  
           Yes  
[If no pain in the past month go to question 14] 
If Yes, 
4 a. How many years ago did your facial pain begin for the first time? _______years ago 
 
b. How many months ago did your facial pain begin for the first time?  _______months 
ago 
5. Is your facial pain persistent, recurrent or was it only a one-time problem? Persistent  
           Recurrent  
           One-Time  
6. Have you ever gone to a physician, dentist, chiropractor or other health professional for 
facial ache or pain?       No 
Yes, in the last six months 
Yes, more than six months ago 
 
7. How would you rate your facial pain on a 0 to 10 scale at the present time, that is right 
now, where 0 is "no pain" and 10 is "pain as bad as could be"?  
NO PAIN         PAIN AS BAD 
          AS COULD BE 
 0 1 2 3 4 5 6 7 8 9  10 
 
8. In the past six months, how intense was your worst pain rated on a 0 to 10 scale where 0 
is  
"no pain" and 10 is "pain as bad as could be"?  
NO PAIN         PAIN AS BAD 
          AS COULD BE 
 0 1 2 3 4 5 6 7 8 9  10 
 
9.  In the past six months, on the average, how intense was your pain rated on a 0 to 10 
scale where 0 is "no pain" and 10 is "pain as bad as could be"? [That is, your usual pain at 
times you were experiencing pain].  
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NO PAIN         PAIN AS BAD 
          AS COULD BE 
 0 1 2 3 4 5 6 7 8 9  10 
10. About how many (e.g. 60) days in the last six months have you been kept from your 
usual activities (work, school or housework) because of facial pain?  _________DAYS 
 
11. In the past six months, how much has facial pain interfered with your daily activities rated 
on a 0 to 10 scale where 0 is "no interference" and 10 is "unable to carry on any activities"?  
          UNABLE TO 
          CARRY ON ANY 
NO INTERFERENCE        ACTIVITIES 
0 1 2 3 4 5 6 7 8 9 10 
 
12. In the past six months, how much has facial pain changed your ability to take part in 
recreational, social and family activities where 0 is "no change" and 10 is "extreme change"?  
EXTREME 
NO CHANGE         CHANGE 
 0 1 2 3 4 5 6 7 8 9  10 
 
13. In the past six months, how much has facial pain changed your ability to work including 
housework) where 0 is "no change" and 10 is "extreme change"? 
EXTREME 
NO CHANGE         CHANGE 
 0 1 2 3 4 5 6 7 8 9  10 
 
14 a. Have you ever had your jaw lock or catch so that it won't open all the way?  
No  
    Yes  
If Yes, 
b. Was this limitation in jaw opening severe enough to interfere with your ability to eat? 
 No  
    Yes  
15 a. Does your jaw click or pop when you open or close your mouth or when chewing? 
No  
Yes 
b. Does your jaw make a grating or grinding noise when it opens and closes or when 
chewing?          No  
Yes 
c. Have you been told, or do you notice that you grind your teeth or clench your jaw while 
 sleeping at night?        No  
Yes 
d. During the day, do you grind your teeth or clench your jaw? 
No  
 Yes 
    
e. Does your jaw ache or feel stiff when you wake up in the morning?   No 
Yes 
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f. Do you have noises or ringing in your ears?      No 
Yes 
  
g. Does your bite feel uncomfortable or unusual? 
No  
           Yes  
16 a. Do you have rheumatoid arthritis, lupus, or other systemic arthritic disease? 
No 
          Yes  
b. Do you know of anyone in your family who has had any of these diseases? 
No  
     Yes  
c. Have you had or do you have any swollen or painful joints) other than the joints close 
to your  ears (TMJ)?         No  
           Yes  
If Yes, 
d. Is this a persistent pain which you have had for at least one year?   No 
Yes 
 
17 a. Have you had a recent injury to your face or jaw?    No  
           Yes  
If Yes, 
b. Did you have jaw pain before the injury?      No     
           Yes  
 
18. During the last six months have you had a problem with headaches or migraines? 
No  
           Yes  
 
19. What activities does your present jaw problem prevent or limit you from doing? 
 
a. Chewing  No g. Sexual activity No 
 Yes  Yes 
b. Drinking  No h. Cleaning teeth or face No 
 Yes  Yes 
c. Exercising No i. Yawning No 
 Yes  Yes 
d. Eating hard foods No j. Swallowing No 
 Yes  Yes 
e. Eating soft foods No k. Talking No 
 Yes  Yes 
f. Smiling/laughing  No I. Having your usual facial appearance No 
 Yes  Yes 
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21. How good a job do you feel you are doing in taking care of your health overall?   
    Excellent 
   Very good 
   Good 
   Fair 
   Poor 
 
22. How good a job do you feel you are doing in taking care of your oral health?  
  Excellent 
  Very good 
  Good 
  Fair 
  Poor 
 
23. When were you born?   Day_________Month_______Year__________ 
 
 
24. Are you male or female?   Male    
      Female  
 
25. In what country were you born?   ________________________________ 
  
26  a. Does this country best represent your race, national origin or ancestry? 
 
       Yes 
       No 
If No, 
b. What is your country of national origin or ancestry? 
________________________________ 
 
      
27. What is the highest grade or year of regular school that you have completed?  
Never attended or Kindergarten 
Primary School   
High School   
University   
 
28 a. During the past 2 weeks, did you work at a job or business not counting work around the 
house (include unpaid work in the family farm/business)?  
       Yes  
      No 
      N/A 
 
 
If No, 
b. Even though you did not work during the past 2 weeks, did you have a job or business?  
       Yes  
       No  
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       N/A 
 
 
If No, 
c. Were you looking for work or on layoff from a job during those 2 weeks?  
       Yes, looking for work  
       Yes, layoff 
       Yes, both on layoff and looking for work  
       No 
       N/A 
 
 
29. Are you married, widowed, divorced, separated or never been married?  
 
       Married / spouse or defacto in household  
       Married / spouse or defacto not in 
household  
       Widowed  
       Divorced  
       Separated  
       Never Married  
 
30. Which of the following best represents your total combined household income during the 
past 12 months?  
$0-$14,999   $25,000-$34,999   $50,000 or more 
 
$15,000-$24,999  $35,000-$49,999 
 
Dworkin and LeResche, 1992. 
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Appendix 4 
 
PCS  
Sullivan MJL, Bishop S, Pivik J. (1995) 
 
Everyone experiences painful situations at some point in their lives.  Such 
experiences may include headaches, tooth pain, joint or muscle pain.  People are 
often exposed to situations that may cause pain such as illness, injury, dental 
procedures or surgery. 
 
Instructions:    
We are interested in the types of thoughts and feelings that you have when you are 
in pain.  Listed below are thirteen statements describing different thoughts and 
feelings that may be associated with pain.  Using the following scale, please indicate 
the degree to which you have these thoughts and feelings when you are 
experiencing pain. 
 
 
RATING  0  1  2  3  4  
MEANING  Not at all  To a slight 
degree  
To a 
moderate 
degree  
To a great 
degree  
All the time  
 
When I’m in pain …  
Number  Statement  Rating 
1  I worry all the time about whether the pain will end.    
2  I feel I can’t go on.    
3  It’s terrible and I think it’s never going to get any better    
4  It’s awful and I feel that it overwhelms me.    
5  I feel I can’t stand it anymore    
6  I become afraid that the pain will get worse.    
7  I keep thinking of other painful events    
8  I anxiously want the pain to go away    
9  I can’t seem to keep it our of my mind    
10  I keep thinking about how much it hurts.    
11  I keep thinking about how badly I want the pain to stop    
12  There’s nothing I can do to reduce the intensity of the pain    
13 I wonder whether something serious may happen  
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Appendix 5 
DASS  
(Lovibond & Lovibond, 1996) 
 
Please read each statement and circle a number 0, 1, 2 or 3 which indicates how much the 
statement applied to you over the past week. There are no right or wrong answers. Do not 
spend too much time on any statement. The rating scale is as follows: 
0  Did not apply to me at all 
1   Applied to me to some degree, or some of the time 
2   Applied to me to a considerable degree, or a good part of time 
3   Applied to me very much, or most of the time 
 
1 I was aware of dryness of my mouth 0 1 2 3 
2 I couldn't seem to experience any positive feeling at all 0 1 2 3 
3 
I experienced breathing difficulty (eg. excessively rapid 
breathing, 
breathlessness in the absence of physical exertion) 
0 1 2 3 
4 I tended to over-react to situations 0 1 2 3 
5 I found it difficult to relax 0 1 2 3 
6 I felt that I had nothing to look forward to 0 1 2 3 
7 I felt that I was using a lot of nervous energy 0 1 2 3 
8 I felt I wasn't worth much as a person 0 1 2 3 
9 I felt that l was rather touchy 0 1 2 3 
10 I felt scared without any good reason 0 1 2 3 
11 I found it hard to wind down 0 1 2 3 
12 
I was aware of the action of my heart in the absence of 
physical exertion (eg, sense of heart rate increase, heart 
missing a beat) 
0 1 2 3 
13 I felt down hearted and blue 0 1 2 3 
14 I felt I was close to panic 0 1 2 3 
15 I was unable to become enthusiastic about anything 0 1 2 3 
16 
I was intolerant of anything that kept me from getting on with 
what I was doing 
0 1 2 3 
17 I felt that life was meaningless 0 1 2 3 
18 I found myself getting agitated 0 1 2 3 
19 
I was worried about situations in which I might panic and 
make a fool of myself 
0 1 2 3 
20 I experienced trembling (eg, in the hands) 0 1 2 3 
21 I found it difficult to work up the initiative to do things 0 1 2 3 
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